Andrew Kenneth Burroughs

Q: What Schools Are Affiliated With Andrew Kenneth Burroughs

Andrew Kenneth Burroughs is affiliated with the following schools: University of Liverpool, University College London

Andrew Kenneth Burroughs's AcademicInfluence.com Rankings

Philosophy

#3904

World Rank

#6223

Historical Rank

Logic

#1491

World Rank

#2256

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Why Is Andrew Kenneth Burroughs Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Andrew K. Burroughs was a British physician, researcher and teacher. He is renowned for his wide contribution to the field of Hepatology; he has been termed one of the greatest hepatologists of our times and the true representative of Dame Sheila Sherlock's legacy.

(See a Problem?)

Andrew Kenneth Burroughs's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. (2001) (3999)
International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. (1999) (2667)
Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. (2009) (1584)
Hepatocellular carcinoma (2003) (1120)
Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis. (2010) (938)
Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis. (2005) (881)
Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis. (2007) (865)
Transarterial Therapy for Hepatocellular Carcinoma: Which Technique Is More Effective? A Systematic Review of Cohort and Randomized Studies (2007) (771)
Evolution of indications and results of liver transplantation in Europe. A report from the European Liver Transplant Registry (ELTR). (2012) (736)
Bacterial infections in cirrhosis: a position statement based on the EASL Special Conference 2013. (2014) (723)
Elastography for the diagnosis of severity of fibrosis in chronic liver disease: a meta-analysis of diagnostic accuracy. (2011) (663)
Heterogeneity of Patients with Intermediate (BCLC B) Hepatocellular Carcinoma: Proposal for a Subclassification to Facilitate Treatment Decisions (2012) (554)
EASL Clinical Practice Guidelines: Liver transplantation. (2016) (502)
A Systematic Review of Microvascular Invasion in Hepatocellular Carcinoma: Diagnostic and Prognostic Variability (2012) (446)
Indications, methods, and outcomes of percutaneous liver biopsy in England and Wales: an audit by the British Society of Gastroenterology and the Royal College of Physicians of London. (1995) (439)
Bacterial infection is independently associated with failure to control bleeding in cirrhotic patients with gastrointestinal hemorrhage (1998) (434)
Portal hypertension and variceal bleeding: An AASLD single topic symposium (1998) (421)
An appraisal of the histopathological assessment of liver fibrosis (2006) (412)
Systematic review: the model for end‐stage liver disease – should it replace Child‐Pugh's classification for assessing prognosis in cirrhosis? (2005) (399)
Transjugular liver biopsy--indications, adequacy, quality of specimens, and complications--a systematic review. (2007) (354)
Levels of alkaline phosphatase and bilirubin are surrogate end points of outcomes of patients with primary biliary cirrhosis: an international follow-up study. (2014) (346)
Prevention of first bleeding in cirrhosis. A meta-analysis of randomized trials of nonsurgical treatment. (1992) (328)
3-month and 12-month mortality after first liver transplant in adults in Europe: predictive models for outcome (2006) (328)
Hepatic venous pressure gradient predicts development of hepatocellular carcinoma independently of severity of cirrhosis. (2009) (328)
Hemostasis and thrombosis in patients with liver disease: the ups and downs. (2010) (324)
Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: a phase 2 randomised placebo-controlled trial (2011) (320)
Transjugular intrahepatic portosystemic shunt compared with endoscopic treatment for prevention of variceal rebleeding: A meta‐analysis (1999) (307)
Bacterial infection in the pathogenesis of variceal bleeding (1999) (304)
A systematic review of the performance of the model for end‐stage liver disease (MELD) in the setting of liver transplantation (2006) (300)
Development and Validation of a Scoring System to Predict Outcomes of Patients With Primary Biliary Cirrhosis Receiving Ursodeoxycholic Acid Therapy. (2015) (299)
Definitions, methodology and therapeutic strategies in portal hypertension. A Consensus Development Workshop, Baveno, Lake Maggiore, Italy, April 5 and 6, 1990. (1992) (298)
Seeding following percutaneous diagnostic and therapeutic approaches for hepatocellular carcinoma. What is the risk and the outcome? Seeding risk for percutaneous approach of HCC. (2007) (297)
Randomised controlled trials of ursodeoxycholic-acid therapy for primary biliary cirrhosis: a meta-analysis (1999) (294)
EASL and mRECIST responses are independent prognostic factors for survival in hepatocellular cancer patients treated with transarterial embolization. (2011) (293)
Clinical outcomes of radiofrequency ablation, percutaneous alcohol and acetic acid injection for hepatocelullar carcinoma: a meta-analysis. (2010) (279)
Computer‐assisted image analysis of liver collagen: Relationship to Ishak scoring and hepatic venous pressure gradient (2009) (278)
A simple prognostic scoring system for patients receiving transarterial embolisation for hepatocellular cancer (2013) (269)
Special article Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference (2001) (268)
The UK‐PBC risk scores: Derivation and validation of a scoring system for long‐term prediction of end‐stage liver disease in primary biliary cholangitis (2016) (251)
A systematic review of the quality of liver biopsy specimens. (2006) (250)
Liver grafts from anti-hepatitis B core positive donors: a systematic review. (2010) (246)
The Eurotransplant Donor Risk Index in Liver Transplantation: ET‐DRI (2012) (244)
Dense fine-mapping study identifies new susceptibility loci for primary biliary cirrhosis (2012) (241)
Effect of multifactorial treatment on non-alcoholic fatty liver disease in metabolic syndrome: a randomised study (2006) (241)
Renal failure and cirrhosis: a systematic review of mortality and prognosis. (2012) (235)
Tacrolimus versus microemulsified ciclosporin in liver transplantation: the TMC randomised controlled trial (2002) (234)
International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways (2015) (233)
Acute-on-chronic liver failure (2015) (233)
Randomized, double-blind, placebo-controlled trial of somatostatin for variceal bleeding. Emergency control and prevention of early variceal rebleeding. (1990) (228)
Embolization of large spontaneous portosystemic shunts for refractory hepatic encephalopathy: A multicenter survey on safety and efficacy (2013) (225)
A randomized, controlled trial of medical therapy versus endoscopic ligation for the prevention of variceal rebleeding in patients with cirrhosis. (2002) (221)
Selection of patients for liver transplantation and allocation of donated livers in the UK (2007) (216)
β‐Blockers protect against spontaneous bacterial peritonitis in cirrhotic patients: a meta‐analysis (2009) (215)
Obesity is an independent risk factor for clinical decompensation in patients with cirrhosis (2011) (213)
Incidence, prevalence, and clinical significance of abnormal hematologic indices in compensated cirrhosis. (2009) (212)
Liver transplantation for acute liver failure in Europe: outcomes over 20 years from the ELTR database. (2012) (210)
Liver transplantation for Budd-Chiari syndrome: A European study on 248 patients from 51 centres. (2006) (204)
Malnutrition and sarcopenia predict post‐liver transplantation outcomes independently of the Model for End‐stage Liver Disease score (2016) (203)
Enhanced thrombin generation in patients with cirrhosis‐induced coagulopathy (2010) (198)
Bacterial infection in cirrhosis impairs coagulation by a heparin effect: a prospective study. (2002) (193)
Prevention of variceal rebleeding (2003) (188)
Bleeding ectopic varices--treatment with transjugular intrahepatic porto-systemic shunt (TIPS) and embolisation. (2004) (185)
Reduced exposure to calcineurin inhibitors early after liver transplantation prevents recurrence of hepatocellular carcinoma. (2013) (170)
Hepatic venous pressure measurement: An old test as a new prognostic marker in cirrhosis? (1997) (169)
Review article: portal vein thrombosis – new insights into aetiology and management (2005) (168)
The Place of Liver Transplantation in the Treatment of Hepatic Epitheloid Hemangioendothelioma: Report of the European Liver Transplant Registry (2007) (166)
Cytomegalovirus Replication Kinetics in Solid Organ Transplant Recipients Managed by Preemptive Therapy (2012) (164)
Improvement in renal function in hepatorenal syndrome with N-acetylcysteine (1999) (164)
Patients with liver cirrhosis suffer from primary haemostatic defects? Fact or fiction? (2011) (162)
Human herpesviruses 6 and 7 as potential pathogens after liver transplant: Prospective comparison with the effect of cytomegalovirus (1999) (162)
Hepatic artery thrombosis after orthotopic liver transplantation: A review of nonsurgical causes (2001) (162)
Controversies in the management of bleeding esophageal varices. (1989) (161)
Different methods of creatinine measurement significantly affect MELD scores (2005) (161)
LAMIVUDINE WITHOUT HBIg FOR PREVENTION OF GRAFT REINFECTION BY HEPATITIS B: LONG-TERM FOLLOW-UP (2000) (161)
Cirrhotics with variceal hemorrhage: The importance of the time interval between admission and the start of analysis for survival and rebleeding rates (1989) (160)
Reconstitution of EBV-specific T cell immunity in solid organ transplant recipients. (1998) (160)
Thrombopoietin concentrations are low in patients with cirrhosis and thrombocytopenia and are restored after orthotopic liver transplantation (1999) (159)
Evaluation of coagulation abnormalities in acute liver failure. (2012) (156)
"Salvage" transjugular intrahepatic portosystemic shunts: gastric fundal compared with esophageal variceal bleeding. (1998) (155)
"Salvage" Transjugular Intrahepatic Portosystemic Shunts: Gastric Fundal Compared With Esophageal Variceal Bleeding (1998) (151)
Systemic treatment and liver transplantation for hepatocellular carcinoma: two ends of the therapeutic spectrum. (2004) (150)
Impact of primary biliary cirrhosis on perceived quality of life: The UK‐PBC national study (2013) (150)
Cost-effectiveness of non-invasive methods for assessment and monitoring of liver fibrosis and cirrhosis in patients with chronic liver disease: systematic review and economic evaluation. (2015) (149)
Report of the monothematic EASL conference on liver transplantation for viral hepatitis (Paris, France, January 12-14, 2006). (2006) (149)
Review article: renal function assessment in cirrhosis – difficulties and alternative measurements (2007) (147)
Review article: scoring systems for assessing prognosis in critically ill adult cirrhotics (2006) (146)
Late hepatic artery thrombosis after orthotopic liver transplantation (2003) (146)
A predictive model for failure to control bleeding during acute variceal haemorrhage. (1999) (143)
The Use of Fatty Liver Grafts in Modern Allocation Systems: Risk Assessment by the Balance of Risk (BAR) Score (2012) (143)
Assessing health‐related quality of life pre– and post–liver transplantation: A prospective multicenter study (2002) (142)
Microbial mimics are major targets of crossreactivity with human pyruvate dehydrogenase in primary biliary cirrhosis. (2004) (138)
Tacrolimus Trough Levels, Rejection and Renal Impairment in Liver Transplantation: A Systematic Review and Meta‐Analysis (2012) (135)
Stratification of hepatocellular carcinoma risk in primary biliary cirrhosis: a multicentre international study (2015) (134)
Gastric endoscopic features in portal hypertension: final report of a consensus conference, Milan, Italy, September 19, 1992. (1994) (134)
TIPS for acute and chronic Budd-Chiari syndrome: a single-centre experience. (2003) (133)
A self-expanding metal stent for complicated variceal hemorrhage: experience at a single center. (2010) (133)
Transjugular intrahepatic portosystemic shunt. (1999) (132)
Platelet count is not a predictor of the presence or development of gastroesophageal varices in cirrhosis (2007) (132)
Transjugular Intrahepatic Portosystemic Shunt versus Endoscopic Therapy: Randomized Trials for Secondary Prophylaxis of Variceal Bleeding: an Updated Meta-Analysis (2002) (130)
Non-invasive assessment of liver fibrosis (2012) (129)
Female Liver Transplant Recipients with the Same GFR as Male Recipients Have Lower MELD Scores—A Systematic Bias (2007) (126)
Thromboelastography with citrated blood: comparability with native blood, stability of citrate storage and effect of repeated sampling (2004) (125)
Unmasking of α-Fetoprotein-Specific CD4+ T Cell Responses in Hepatocellular Carcinoma Patients Undergoing Embolization1 (2007) (124)
New therapeutic paradigm for patients with cirrhosis (2012) (122)
Collagen proportionate area is superior to other histological methods for sub-classifying cirrhosis and determining prognosis. (2014) (121)
Serum ferritin is a discriminant marker for both fibrosis and inflammation in histologically proven non‐alcoholic fatty liver disease patients (2011) (120)
Assessment of therapeutic benefit of antiviral therapy in chronic hepatitis C: is hepatic venous pressure gradient a better end point? (2002) (119)
Methods to decrease blood loss and transfusion requirements for liver transplantation. (2011) (118)
Idiopathic acute fatty liver of pregnancy in 12 patients. (1982) (118)
Liver transplantation for HCV cirrhosis: Improved survival in recent years and increased severity of recurrent disease in female recipients: Results of a long term retrospective study (2007) (117)
Adrenocortical dysfunction in liver disease: A systematic review (2012) (116)
Risk factors for recurrence of primary sclerosing cholangitis after liver transplantation (2008) (115)
Primary biliary cirrhosis is characterized by IgG3 antibodies cross‐reactive with the major mitochondrial autoepitope and its Lactobacillus mimic (2005) (115)
Human cytomegalovirus (HCMV) replication dynamics in HCMV-naive and -experienced immunocompromised hosts. (2002) (115)
A randomised phase II/III trial of 3-weekly cisplatin-based sequential transarterial chemoembolisation vs embolisation alone for hepatocellular carcinoma (2013) (114)
Thrombelastographic changes and early rebleeding in cirrhotic patients with variceal bleeding (1998) (110)
Immunosuppression and donor age with respect to severity of HCV recurrence after liver transplantation (2005) (109)
Effect of functional grade and etiology on in vivo hepatic phosphorus‐31 magnetic resonance spectroscopy in cirrhosis: Biochemical basis of spectral appearances (1995) (108)
Pegylated‐interferon and ribavirin in liver transplant candidates and recipients with HCV cirrhosis: systematic review and meta‐analysis of prospective controlled studies (2008) (105)
Pitfalls in studies of prophylactic therapy for variceal bleeding in cirrhotics (1986) (104)
Validation of the donor risk index in orthotopic liver transplantation within the Eurotransplant region (2012) (104)
Assessment of fibrosis and cirrhosis in liver biopsies: an update. (2011) (103)
Transplantation for alcoholic liver disease. (2002) (101)
Molecular mimicry in liver disease (1992) (101)
Disseminated intravascular coagulation in liver cirrhosis: fact or fiction? (1999) (100)
Does the severity of primary sclerosing cholangitis influence the clinical course of associated ulcerative colitis? (2011) (100)
Dystonia with Brain Manganese Accumulation Resulting From SLC30A10 Mutations: A New Treatable Disorder (2012) (100)
Salvage tips for uncontrolled variceal bleeding. (2002) (99)
Kinetics of cytomegalovirus load decrease in solid-organ transplant recipients after preemptive therapy with valganciclovir. (2005) (99)
Liver transplantation for HBV-related cirrhosis in Europe: an ELTR study on evolution and outcomes. (2013) (94)
RIFLE classification as predictive factor of mortality in patients with cirrhosis admitted to intensive care unit (2009) (93)
THE ROLE OF DIFFERENT IMMUNOSUPPRESSION IN THE LONG-TERM HISTOLOGICAL OUTCOME OF HCV REINFECTION AFTER LIVER TRANSPLANTATION FOR HCV CIRRHOSIS (2001) (93)
Treatment outcomes for hepatocellular carcinoma using chemoembolization in combination with other therapies. (2006) (92)
Risk factors for recurrent primary sclerosing cholangitis after liver transplantation. (2015) (92)
Cirrhotics admitted to intensive care unit: the impact of acute renal failure on mortality (2007) (92)
Infection and hemostasis in decompensated cirrhosis: A prospective study using thrombelastography (1999) (91)
The natural history of varices. (1993) (91)
Endoscopic extraction of bile duct stones: management related to stone size. (1993) (91)
Peptic ulcer and its course in cirrhosis: an endoscopic and clinical prospective study. (1995) (91)
Update on the classification, assessment of prognosis and therapy of Budd–Chiari syndrome (2005) (90)
Single portal pressure measurement predicts survival in cirrhotic patients with recent bleeding (1999) (90)
Transient Elastography for Diagnosis of Stages of Hepatic Fibrosis and Cirrhosis in People with Alcoholic Liver Disease (2017) (90)
Early tacrolimus exposure after liver transplantation: relationship with moderate/severe acute rejection and long-term outcome. (2013) (90)
Prognostic models in cirrhotics admitted to intensive care units better predict outcome when assessed at 48 h after admission (2008) (89)
Targeting portal pressure measurements: A critical reappraisal (2004) (89)
Clinical utility of viscoelastic tests of coagulation in patients with liver disease (2013) (88)
Risk factors associated with early hepatic artery thrombosis after orthotopic liver transplantation – univariable and multivariable analysis (2011) (87)
A randomized, controlled trial comparing ganciclovir to ganciclovir plus foscarnet (each at half dose) for preemptive therapy of cytomegalovirus infection in transplant recipients. (2004) (86)
Acute variceal haemorrhage in the United Kingdom: patient characteristics, management and outcomes in a nationwide audit. (2014) (86)
Randomized Controlled Trial of Tacrolimus Versus Microemulsified Cyclosporin (TMC) in Liver Transplantation: Poststudy Surveillance to 3 Years (2007) (85)
Digital image analysis of liver collagen predicts clinical outcome of recurrent hepatitis C Virus 1 year after liver transplantation (2011) (85)
TACE versus TAE as therapy for hepatocellular carcinoma (2008) (84)
Distal spleno-renal shunt versus endoscopic sclerotherapy in the prevention of variceal rebleeding. A meta-analysis of 4 randomized clinical trials. (1992) (83)
Octreotide inhibits the meal‐induced increases in the portal venous pressure of cirrhotic patients with portal hypertension: A double‐blind, placebo‐controlled study (1992) (83)
C-reactive protein and bacterial infection in cirrhosis (2014) (83)
Liver transplantation for chronic viral hepatitis. (1991) (83)
Midterm cost‐effectiveness of the liver transplantation program of England and Wales for three disease groups (2003) (82)
Analysis of intrapulmonary right to left shunt in the hepatopulmonary syndrome. (1998) (82)
How to prevent varices from bleeding: shades of grey--the case for nonselective beta blockers. (2007) (82)
Evidence-Based Gastroenterology and Hepatology (1999) (82)
Liver transplantation: immunosuppression and oncology (2014) (81)
The relationship between liver disease stage and liver fibrosis: a tangled web (2010) (81)
Hepatic venous pressure gradient to assess fibrosis and its progression after liver transplantation for HCV cirrhosis (2007) (80)
Assessment of adrenocortical reserve in stable patients with cirrhosis. (2010) (79)
Antiviral therapy reduces portal pressure in patients with cirrhosis due to HBeAg-negative chronic hepatitis B and significant portal hypertension. (2009) (79)
Bacterial Infections Change Natural History of Cirrhosis Irrespective of Liver Disease Severity (2017) (76)
Liver Transplantation and Recurrent Hepatocellular Carcinoma: Predictive Value of Nodule Size in a Retrospective and Explant Study (2006) (76)
Grading of cellular rejection after orthotopic liver transplantation (1995) (75)
A randomized study comparing ligation with propranolol for primary prophylaxis of variceal bleeding in candidates for liver transplantation (2007) (75)
Results of systematic review and meta-analysis (2015) (75)
Long-term mycophenolate mofetil monotherapy in combination with calcineurin inhibitors for chronic renal dysfunction after liver transplantation (2003) (74)
Hepatic Hemangiosarcoma: An Absolute Contraindication to Liver Transplantation—The European Liver Transplant Registry Experience (2013) (74)
Comparison of the sequential organ failure assessment score with the King's College Hospital criteria and the model for end‐stage liver disease score for the prognosis of acetaminophen‐induced acute liver failure (2012) (74)
Current management of hepatitis B virus infection before and after liver transplantation (2009) (74)
Management of variceal haemorrhage in cirrhotic patients (2001) (72)
Transarterial chemoembolization and bland embolization for hepatocellular carcinoma. (2014) (72)
Review article: pruritus in cholestatic and other liver diseases. (2003) (71)
Results of choledochojejunostomy in the treatment of biliary complications after liver transplantation in the era of nonsurgical therapies (2000) (71)
Randomized, double-blind, placebo-controlled trial of somatostatin for variceal bleeding (1990) (71)
A Simulation Modelling Approach to Evaluating Alternative Policies for the Management of the Waiting List for Liver Transplantation (2001) (71)
Systematic review and meta‐analysis of intraoperative versus preoperative endoscopic sphincterotomy in patients with gallbladder and suspected common bile duct stones (2011) (70)
Antibodies against homologous microbial caseinolytic proteases P characterise primary biliary cirrhosis. (2001) (70)
Coagulation and fibrosis in chronic liver disease (2008) (70)
Carcinoid tumour. (1998) (70)
Liver transplantation for neuroendocrine tumour liver metastases. (2015) (70)
Comparison of cystatin C and creatinine-based glomerular filtration rate formulas with 51Cr-EDTA clearance in patients with cirrhosis. (2011) (69)
Cardiovascular effects of octreotide in patients with hepatic cirrhosis (1995) (67)
Azathioprine-induced myelosuppression due to thiopurine methyltransferase deficiency in a patient with autoimmune hepatitis. (1995) (67)
In vivo and in vitro hepatic 31P magnetic resonance spectroscopy and electron microscopy of the cirrhotic liver. (2008) (66)
Prioritization for liver transplantation (2010) (66)
Longitudinal variation in hepatitis C virus (HCV) viraemia and early course of HCV infection after liver transplantation for HCV cirrhosis: the role of different immunosuppressive regimens (1999) (64)
The Royal Free Hospital Score: A Calibrated Prognostic Model for Patients With Cirrhosis Admitted to Intensive Care Unit. Comparison With Current Models and CLIF-SOFA Score (2014) (64)
Adrenal insufficiency in liver disease - what is the evidence? (2007) (64)
Endogenous heparin‐like activity detected by anti‐Xa assay in infected cirrhotic and non‐cirrhotic patients (2004) (64)
Prognosis of cirrhotic patients admitted to intensive care unit: a meta-analysis (2017) (64)
Liver Transplantation in Cirrhotic Patients with Small Hepatocellular Carcinoma: An Analysis of Pre-Operative Imaging, Explant Histology and Prognostic Histologic Indicators (2004) (63)
28 AN INTERNATIONAL STUDY EVALUATING THE FARNESOID X RECEPTOR AGONIST OBETICHOLIC ACID AS MONOTHERAPY IN PBC (2011) (63)
The impact of liver transplantation on the phenotype of primary biliary cirrhosis patients in the UK-PBC cohort. (2013) (63)
Prevention of and Treatment for Hepatitis B Virus Infection After Liver Transplantation in the Nucleoside Analogues Era (2003) (62)
The effects of unfractionated heparin, low molecular weight heparin and danaparoid on the thromboelastogram (TEG): an in-vitro comparison of standard and heparinase-modified TEGs with conventional coagulation assays (2006) (62)
Pitfalls in assessing renal function in patients with cirrhosis--potential inequity for access to treatment of hepatorenal failure and liver transplantation. (2011) (62)
Liver collagen proportionate area predicts decompensation in patients with recurrent hepatitis C virus cirrhosis after liver transplantation (2012) (62)
Autoimmunity and Environment: Am I at risk? (2012) (61)
Should we biopsy each liver mass suspicious for HCC before liver transplantation?--no, please don't. (2005) (61)
Immunosuppression and HCV recurrence after liver transplantation. (2012) (61)
MR imaging of the basal ganglia in chronic liver disease: correlation of T1-weighted and magnetisation transfer contrast measurements with liver dysfunction and neuropsychiatric status (1995) (61)
Cost-effectiveness of noninvasive liver fibrosis tests for treatment decisions in patients with chronic hepatitis C (2014) (60)
Disease-specific cross-reactivity between mimicking peptides of heat shock protein of Mycobacterium gordonae and dominant epitope of E2 subunit of pyruvate dehydrogenase is common in Spanish but not British patients with primary biliary cirrhosis. (2004) (60)
Continuous renal replacement therapy (CRRT) in patients with liver disease: is circuit life different? (2009) (59)
Outcome of recurrent hepatitis C virus after liver transplantation in a randomized trial of tacrolimus monotherapy versus triple therapy (2009) (59)
The effect of non-protein liquid meals on the hepatic venous pressure gradient in patients with cirrhosis. (1990) (58)
Sustained, spontaneous disappearance of serum HCV-RNA under immunosuppression after liver transplantation for HCV cirrhosis. (2005) (58)
103 Multicenter randomized placebo-controlled trial of non-selective beta-blockers in the prevention of the complications of portal hypertension: final results and identification of a predictive factor (2003) (57)
Vitamin E deficiency and its clinical significance in adults with primary biliary cirrhosis and other forms of chronic liver disease. (1987) (57)
Pathogenesis of primary sclerosing cholangitis. (2008) (56)
Extensive homology between the major immunodominant mitochondrial antigen in primary biliary cirrhosis and Helicobacter pylori does not lead to immunological cross‐reactivity (2004) (55)
IS PSEUDOMEMBRANOUS COLITIS INFECTIOUS? (1981) (55)
Transarterial embolization as neo‐adjuvant therapy pretransplantation in patients with hepatocellular carcinoma (2013) (55)
Eosinophils in acute cellular rejection in liver allografts. (1998) (55)
The impact of infection by multidrug‐resistant agents in patients with cirrhosis. A multicenter prospective study (2017) (55)
Novel inflammatory biomarkers of portal pressure in compensated cirrhosis patients (2014) (55)
The evolution in the prioritization for liver transplantation (2012) (54)
Primary prevention of bleeding from esophageal varices. (1999) (53)
Cure of Acanthamoeba cerebral abscess in a liver transplant patient (2008) (53)
The cardiorenal link in advanced cirrhosis. (2012) (53)
Primary biliary cirrhosis after liver transplantation: Influence of immunosuppression and human leukocyte antigen locus disparity (2010) (53)
Induction of autoimmune hepatitis by pegylated interferon in a liver transplant patient with recurrent hepatitis C virus. (2006) (52)
Correction of both prothrombin time and primary haemostasis by recombinant factor VII during therapeutic alcohol injection of hepatocellular cancer in liver cirrhosis. (1999) (52)
An evaluation of emergency sclerotherapy of varices in randomized trials: looking the needle in the eye. (2006) (52)
Digital image analysis of collagen assessment of progression of fibrosis in recurrent HCV after liver transplantation. (2013) (52)
Chronic ecstasy (3,4-methylenedioxymetamphetamine) abuse: a recurrent and unpredictable cause of severe acute hepatitis. (1996) (52)
Development and validation of a mathematical equation to estimate glomerular filtration rate in cirrhosis: The royal free hospital cirrhosis glomerular filtration rate (2017) (52)
Transarterial chemoembolization, transarterial chemotherapy, and intra-arterial chemotherapy for hepatocellular carcinoma treatment. (2010) (51)
Splanchnic vein thrombosis in myeloproliferative neoplasms (2013) (51)
Epstein-Barr Virus as a Trigger of Autoimmune Liver Diseases (2012) (51)
Hepatic venular stenosis after orthotopic liver transplantation (1994) (51)
Primary prophylaxis of variceal bleeding in cirrhotics unable to take β‐blockers: a randomized trial of ligation (2005) (50)
Tumour Size and Differentiation in Predicting Recurrence of Hepatocellular Carcinoma After Liver Transplantation: External Validation of a New Prognostic Score (2008) (50)
Patterns of blood component use in cirrhosis: a nationwide study (2016) (50)
Noninvasive tests for evaluation of fibrosis in HCV recurrence after liver transplantation: a systematic review (2010) (50)
Subclinical Addison's disease: a cause of persistent abnormalities in transaminase values. (1995) (49)
Biliary lavage with corticosteroids in primary sclerosing cholangitis. A clinical, cholangiographic and bacteriological study. (1986) (49)
The prevalence of a heparin‐like effect shown on the thromboelastograph in patients undergoing liver transplantation (2008) (49)
Antimitochondrial antibodies in primary biliary cirrhosis recognize both specific peptides and shared epitopes of the M2 family of antigens (1989) (49)
Hepatic phosphorus-31 magnetic resonance spectroscopy in primary biliary cirrhosis and its relation to prognostic models. (1996) (48)
Anti-tumour necrosis factor agent and liver injury: literature review, recommendations for management. (2014) (48)
Critical illness-related corticosteroid insufficiency in patients with cirrhosis and variceal bleeding. (2011) (48)
Cardiac dysfunction in cirrhosis – does adrenal function play a role? A hypothesis (2012) (47)
Toxicity of high-activity 111In-Octreotide therapy in patients with disseminated neuroendocrine tumours (2000) (47)
Alteration in vascular reactivity in isolated aortic rings from portal vein—constricted rats (1994) (47)
Hepatic venous pressure gradient in 2010: Optimal measurement is key (2010) (47)
Hemostasis in patients with acute kidney injury secondary to acute liver failure. (2013) (47)
Management of varices in patients with cirrhosis (2013) (46)
Angiotensin converting enzyme inhibitors and angiotensin II antagonists as therapy in chronic liver disease (2001) (46)
THE INFLUENCE OF CYTOMEGALOVIRUS VIRAEMIA ON THE OUTCOME OF RECURRENT HEPATITIS C AFTER LIVER TRANSPLANTATION12 (2000) (46)
Smoking as a risk factor for autoimmune liver disease: what we can learn from primary biliary cirrhosis. (2012) (46)
Therapeutic benefit of vaso‐active drugs for acute variceal bleeding: A real pharmacological effect, or a side‐effect of definitions in trials? (1996) (46)
Applications and Limitations of Blood Eosinophilia for the Diagnosis of Acute Cellular Rejection in Liver Transplantation (2003) (45)
Altered intestinal function precedes the appearance of bacterial DNA in serum and ascites in patients with cirrhosis: a pilot study (2010) (45)
Liver Transplantation for Unresectable Neuroendocrine Tumor Liver Metastases (2014) (45)
Antiviral therapy for recurrent liver graft infection with hepatitis C virus. (2010) (44)
Primary Biliary Cirrhosis Associated with Systemic Sclerosis: Diagnostic and Clinical Challenges (2011) (44)
Posttransplantation lymphoproliferative disorder in liver recipients: characteristics, management, and outcome. (1999) (44)
Spontaneous bacterial peritonitis in cirrhotic patients: Is prophylactic propranolol therapy beneficial? (2006) (44)
Fibrosis distribution in explanted cirrhotic livers (2012) (44)
Can non-invasive measurements aid clinical assessment of volume in patients with cirrhosis? (2013) (44)
Sex Differences Associated with Primary Biliary Cirrhosis (2012) (43)
Liver transplantation and hepatitis C virus: systematic review of antiviral therapy. (2005) (43)
A comparison between two strategies for monitoring hepatic function during antituberculous therapy. (2012) (43)
Gastric secretion and peptic ulceration in cirrhosis. (1993) (43)
The Role of E. coli Infection in the Pathogenesis of Primary Biliary Cirrhosis (2011) (43)
Should we routinely measure portal pressure in patients with cirrhosis, using hepatic venous pressure gradient (HVPG) as a guide for prophylaxis and therapy of bleeding and rebleeding? No. (2011) (43)
In vivo and in vitro hepatic phosphorus-31 magnetic resonance spectroscopy and electron microscopy in chronic ductopenic rejection of human liver allografts (1998) (43)
Hepatitis B Virus Infection in HIV-Positive Individuals in the UK Collaborative HIV Cohort (UK CHIC) Study (2012) (42)
Comparison of total cortisol, free cortisol, and surrogate markers of free cortisol in diagnosis of adrenal insufficiency in patients with stable cirrhosis. (2014) (42)
Epithelial Colonies Cultured from Human Explanted Liver in Subacute Hepatic Failure Exhibit Hepatocyte, Biliary Epithelial, and Stem Cell Phenotypic Markers (2003) (42)
Clinical outcome of HCV‐related graft cirrhosis and prognostic value of hepatic venous pressure gradient (2009) (42)
Prevention of variceal rebleeding. (1992) (41)
Psychiatric and Social Outcome of Liver Transplantation (1995) (41)
Inflammation‐based scores do not predict post‐transplant recurrence of hepatocellular carcinoma in patients within milan criteria (2014) (41)
Surgical Repair of Umbilical Hernias in Cirrhosis With Ascites (2011) (41)
Predicting severity and clinical course of acute rejection after liver transplantation using blood eosinophil count (2012) (41)
Urinary tract infection as a risk factor for autoimmune liver disease: from bench to bedside. (2011) (40)
Oral Propranolol Decreases Intestinal Permeability in Patients With Cirrhosis: Another Protective Mechanism Against Bleeding? (2009) (40)
Fibrosis staging in chronic hepatitis C: analysis of discordance between transient elastography and liver biopsy (2009) (40)
Autoantibodies in Autoimmune Pancreatitis (2012) (39)
Significant bacteriuria has prognostic significance in primary biliary cirrhosis. (1989) (39)
Predictors of Re-bleeding and Mortality Among Patients with Refractory Variceal Bleeding Undergoing Salvage Transjugular Intrahepatic Portosystemic Shunt (TIPS) (2019) (38)
The relationship between transient elastography and histological collagen proportionate area for assessing fibrosis in chronic viral hepatitis (2013) (38)
Review article: S‐Adenosyl‐L‐Methionine–a new therapeutic agent in liver disease? (1993) (38)
The difficulty in defining extended donor criteria for liver grafts: the Eurotransplant experience (2013) (38)
A Comparison of Four- Versus Three-Pass Transjugular Biopsy Using a 19-G Tru-Cut Needle and a Randomized Study Using a Cassette to Prevent Biopsy Fragmentation (2009) (37)
Portal hypertension and variceal bleeding (1992) (37)
Diagnostic and clinical utility of antibodies against the nuclear body promyelocytic leukaemia and Sp100 antigens in patients with primary biliary cirrhosis. (2012) (37)
Reversible jaundice in primary biliary cirrhosis due to hyperthyroidism. (1994) (37)
Endoscopic retrograde cholangiography in the diagnosis and endoscopic management of biliary complications after liver transplantation (1996) (37)
Orthotopic liver transplantation for chronic hepatitis in two patients with common variable immunodeficiency. (1995) (36)
The Impact of Aprotinin on Renal Function After Liver Transplantation: An Analysis of 1043 Patients (2007) (36)
Development of ductopaenic liver allograft rejection includes a "hepatitic" phase prior to duct loss. (2000) (36)
Anticoagulation in patients with liver cirrhosis: complication or therapeutic opportunity? (2013) (36)
Diurnal changes of fibrinolysis in patients with liver cirrhosis and esophageal varices (2000) (36)
Recurrent hepatic sarcoidosis following liver transplantation. (1997) (35)
Immunohistochemical studies on the innervation of human transplanted liver (1992) (35)
Review article: the therapeutic and prognostic benefit of portal pressure reduction in cirrhosis (2008) (35)
Multimodality treatment for gastric carcinoid tumor with liver metastases (1998) (35)
Treatment of hepatocellular carcinoma (HCC) by intra-arterial infusion of radio-emitter compounds: trans-arterial radio-embolisation of HCC. (2012) (35)
Long-term immunosuppression without corticosteroids after orthotopic liver transplantation: a positive therapeutic aim. (1996) (34)
Cyclosporin associated headache. (1994) (34)
Ultrasound‐guided liver biopsy in real life: Comparison of same‐day prebiopsy versus real‐time ultrasound approach (2007) (34)
TIPS for refractory ascites: a single-centre experience (2009) (34)
Non-invasive tests for liver fibrosis: encouraging or discouraging results? (2007) (34)
Transarterial Injection of 131I-Lipiodol, Compared with Chemoembolization, in the Treatment of Unresectable Hepatocellular Cancer (2009) (34)
Glucocorticosteroids trigger reactivation of human cytomegalovirus from latently infected myeloid cells and increase the risk for HCMV infection in D+R+ liver transplant patients (2015) (33)
Prevention of the development of varices and first portal hypertensive bleeding episode. (2007) (33)
Treatment of early hepatocellular carcinoma: How to predict and prevent recurrence. (2010) (33)
Duct-to-duct biliary reconstruction following liver transplantation for primary sclerosing cholangitis (1996) (33)
The outcome of hepatitis C virus infection after liver transplantation--is it influenced by the type of immunosuppression? (1999) (33)
Predictors of early rebleeding and mortality after acute variceal hemorrhage in patients with cirrhosis (2009) (33)
Octreotide in variceal bleeding. (1994) (33)
Prediction of short-term survival with an application in primary biliary cirrhosis. (1992) (32)
Biochemical criteria at 1 year are not robust indicators of response to ursodeoxycholic acid in early primary biliary cirrhosis: results from a 29-year cohort study (2013) (32)
Assessment of blood coagulation in severe liver disease using thromboelastography: use of citrate storage versus native blood (2003) (32)
Infection rates with and without T-tube splintage of common bile duct anastomosis in liver transplantation (1998) (32)
Heparin-like effect contributes to the coagulopathy in patients with acute liver failure undergoing liver transplantation (2009) (32)
Incidence and risk factors for the development of prolonged and severe intrahepatic cholestasis after liver transplantation (2006) (32)
MELD is not enough--enough of MELD? (2005) (32)
Transient elastography for diagnosis of stages of hepatic fibrosis and cirrhosis in people with alcoholic liver disease. (2015) (31)
Monitoring surgical and medical outcomes: the Bernoulli cumulative SUM chart. A novel application to assess clinical interventions (2005) (31)
Routine endoscopic retrograde cholangiography in the detection of early biliary complications after liver transplantation (2002) (31)
Exploring the bidirectional interactions between human cytomegalovirus and hepatitis C virus replication after liver transplantation (2007) (31)
Tips for portal vein thrombosis (pvt) in cirrhosis: not only unblocking a pipe. (2011) (30)
Esophageal staple transection as a salvage procedure after failure of acute injection sclerotherapy (1992) (30)
A comparison of kaolin-activated versus nonkaolin-activated thromboelastography in native and citrated blood (2008) (30)
The ontogeny of liver copper metabolism in the guinea pig: Clues to the etiology of Wilson's disease (1986) (30)
Long‐term ursodeoxycholic acid therapy for primary biliary cirrhosis: a follow‐up to 12 years (2005) (30)
Conduction and excitability properties of peripheral nerves in end‐stage liver disease (2007) (30)
Adipokines levels are associated with the severity of liver disease in patients with alcoholic cirrhosis. (2015) (29)
Infection in solid-organ transplant recipients. (2008) (29)
Prothrombin Complex Concentrates for Coagulopathy in Liver Disease: Single‐Center, Clinical Experience in 105 Patients (2019) (28)
The Role ofE. coliInfection in the Pathogenesis of Primary Biliary Cirrhosis (2010) (28)
Successful recanalization of portal vein thrombosis before liver transplantation using transjugular intrahepatic portosystemic shunt (2001) (28)
Variceal bleeding and portal hypertensive gastropathy (2001) (28)
Aprotinin and the risk of thrombotic complications after liver transplantation: A retrospective analysis of 1492 patients (2009) (28)
Terbinafine-induced hepatic dysfunction. (2001) (27)
Posttransplantation prevention and treatment of recurrent hepatitis C (2000) (27)
Transjugular liver biopsy in patients with diffuse liver disease: comparison of three cores with one or two cores for accurate histological interpretation (2007) (27)
Recurrent hepatitis C after liver transplantation (2000) (27)
Immunogenicity and safety of an experimental adjuvanted hepatitis B candidate vaccine in liver transplant patients (2006) (27)
Sample size requirement for digital image analysis of collagen proportionate area in cirrhotic livers (2013) (26)
Terlipressin therapy for renal failure in cirrhosis (2010) (26)
Management of recurrent hepatitis C after liver transplantation (2001) (26)
The relationship between liver function and portal pressure: what comes first, the chicken or the egg? (2005) (26)
Small hepatocellular carcinomas in cirrhotic explant livers: Identification by macroscopic examination and lipiodol localization (1997) (25)
Treatments in hepatology (1995) (25)
Is banding ligation for primary prevention of variceal bleeding as effective as beta‐blockers, and is it safe? (2006) (25)
King's criteria, APACHE II, and SOFA scores in acute liver failure (2006) (25)
Bowel Sounds Analysis: A Novel Noninvasive Method for Diagnosis of Small-Volume Ascites (2003) (25)
Lack of agreement for defining ‘clinical suspicion of rejection’ in liver transplantation: a model to select candidates for liver biopsy (2015) (25)
Severe venoocclusive disease after liver transplantation treated with transjugular intrahepatic portosystemic shunt. (2006) (25)
The Hepatic Artery, Portal Venous System and Portal Hypertension: The Hepatic Veins and Liver in Circulatory Failure (2011) (24)
Identification of latent myeloproliferative disease in patients with Budd‐Chiari syndrome using X‐chromosome inactivation patterns and in vitro erythroid colony formation (1995) (24)
Hepatocellular carcinoma: indications for liver transplantation (2003) (24)
The Low Incidence of Bacterial Infections Could Be a Protective Factor Against Variceal Bleeding Per Se in Hemodynamic Responders to Propranolol (2006) (24)
Somatostatin and octreotide for variceal bleeding. (1991) (24)
Pharmacological Treatment of Acute Variceal Bleeding (1998) (23)
Pharmacological treatment of portal hypertension. (1995) (23)
For the EASL Panel of Experts on hepatocellular carcinoma (2001) (23)
Prolonging survival in patients with cirrhosis: old drugs with new indications. (2010) (23)
Effect of functional grade and etiology on in vivo hepatic phosphorus-31 magnetic resonance spectroscopy in cirrhosis: Biochemical basis of spectral appearances*1 (1995) (23)
Blood and graft eosinophils in acute cellular rejection of liver allografts. (2001) (23)
Bleeding time in patients with hepatic cirrhosis. (1990) (23)
Liver: Transjugular liver biopsy yields high-quality samples (2012) (22)
OP02 The first new monotherapy therapeutic PBC study in a decade? An international study evaluating the farnesoid X receptor agonist obeticholic acid in PBC (2011) (22)
Surveillance and diagnosis of hepatocellular carcinoma in patients with cirrhosis. (2009) (22)
Role of Vasoactive Drugs in the Treatment of Bleeding Oesophageal Varices (1999) (22)
Transarterial chemoembolisation is not superior to embolisation alone: the recent European Association for the Study of the Liver (EASL) - European Organisation for Research and Treatment of Cancer (EORTC) guidelines. (2013) (22)
Tracking the source of the hepatitis B virus-specific CD8 T cells during lamivudine treatment. (2003) (22)
Rheumatoid Arthritis and Primary Biliary Cirrhosis: Cause, Consequence, or Coincidence? (2012) (22)
Betablockers induce cardiac chronotropic incompetence. (2012) (22)
Combined HLA‐DR and ‐DQ disparity is associated with a stable course of ulcerative colitis after liver transplantation for primary sclerosing cholangitis (2007) (22)
Antiviral prophylactic intervention for chronic hepatitis C virus in patients undergoing liver transplantation. (2010) (22)
Optimizing emergency care of upper gastrointestinal bleeding in cirrhotic patients. (1998) (22)
Carcinoid tumour (1998) (22)
Long‐Term Outcomes of Liver Transplantation in Type 1 Gaucher Disease (2010) (22)
The pharmacokinetics of intravenous ondansetron in patients with hepatic impairment. (1993) (22)
Intra-operative vs pre-operative endoscopic sphincterotomy in patients with gallbladder and common bile duct stones (2012) (22)
Long‐term follow‐up of immunosuppressive monotherapy in liver transplantation: tacrolimus and microemulsified cyclosporin (2011) (21)
Tips for acute and chronic Budd-Chiari syndrome: (2003) (21)
Hepatocellular ballooning after liver transplantation: a light and electronmicroscopic study with clinicopathological correlation (1991) (21)
Systematic review of radiological imaging for hepatocellular carcinoma in cirrhotic patients. (2004) (21)
Duct‐to‐duct biliary reconstruction in orthotopic liver transplantation for primary sclerosing cholangitis: a viable and safe alternative (2012) (21)
Xanthine oxidoreductase is present in bile ducts of normal and cirrhotic liver. (2004) (21)
Endogenous heparinoids contribute to coagulopathy in patients with liver disease. (2008) (21)
Liver transplantation complicated by embedded transjugular intrahepatic portosystemic shunt: A new method for portal anastomosis—a surgical salvage procedure (2000) (20)
Future treatments of cirrhosis (2014) (20)
Idiopathic fibrosing pancreatitis and Crohn's disease: an interesting association. (2000) (20)
Interferon for interferon nonresponding and relapsing patients with chronic hepatitis C. (2013) (20)
Quantification of fibrosis by collagen proportionate area predicts hepatic decompensation in hepatitis C cirrhosis (2015) (20)
Liver Cirrhosis: From Pathophysiology to Disease Management (2008) (20)
Infections in solid organ transplantation (1994) (20)
Autoimmune hepatitis associated with Kikuchi–Fujimoto's disease (2008) (19)
Reduced fibrosis in recurrent HCV with tacrolimus, azathioprine and steroids versus tacrolimus: randomised trial long term outcomes (2013) (19)
Liver in haematological disorders. (2013) (19)
Budd-Chiari syndrome: blocked veins, open mind (1999) (19)
Validating non-invasive markers of fibrosis: the need for a new histological reference standard (2010) (19)
Modelling cytomegalovirus replication patterns in the human host: factors important for pathogenesis (2006) (19)
Muscle cramps in cirrhosis: the therapeutic value of quinine. Is it underused? (2008) (19)
Incarcerated umbilical hernia after large volume paracentesis for refractory ascites. (2010) (18)
Disopyramide and warfarin interaction. (1977) (18)
LP11 : Warfarin anticoagulation for liver fibrosis in patients transplanted for hepatitis C (WAFT-C): results at one year (2015) (18)
TIPS for veno‐occlusive disease: Is the contraindication real? (2005) (18)
Survival of cirrhotic patients with early hepatocellular carcinoma treated by percutaneous ethanol injection or liver transplantation (2004) (18)
Primary prophylaxis of variceal bleeding. (2011) (18)
Differential Effects of Prednisolone and Azathioprine on the Development of Human Cytomegalovirus Replication Post Liver Transplantation (2007) (18)
Prognostic impact of lactate in acute liver failure (2008) (18)
Review article: the transjugular intrahepatic portosystemic shunt (TIPS) in the treatment of portal hypertension (1994) (18)
Assessment of reproducibility of creatinine measurement and MELD scoring in four liver transplant units in the UK. (2010) (17)
Gastrointestinal bleeding: Carvedilol—the best β-blocker for primary prophylaxis? (2009) (17)
Evidence-based diagnosis and locoregional therapy for hepatocellular carcinoma (2008) (17)
Purpura Fulminans Associated with Lactobacillus paracasei Liver Abscess (2007) (17)
Progress in Liver Diseases (1995) (17)
LAMIVUDINE PROPHYLAXIS - A NEW STRATEGY FOR PREVENTION OF REINFECTION IN LIVER-TRANSPLANTATION FOR HEPATITIS-B DNA POSITIVE CIRRHOSIS (1995) (17)
Morphometric image analysis and eosinophil counts in human liver allografts (1995) (17)
Liver transplantation for severe alcoholic hepatitis saves lives. (2012) (17)
Pharmacological therapy for portal hypertension: rationale and results. (1995) (17)
Gastrointestinal sarcoidosis. A review. (2007) (17)
Intrahepatic cholestasis after liver transplantation. (2008) (16)
Adult “idiopathic” extrahepatic venous thrombosis (1992) (16)
Is hydrophobia necessary for the hepatologist prescribing nonselective beta‐blockers in cirrhosis? (2011) (16)
Review article: β‐adrenoceptor blockers for the treatment of portal hypertension (1987) (16)
Transjugular Intrahepatic Portosystemic Shunt (TIPS), the Preferred Therapeutic Option for Budd Chiari Syndrome Associated with Portal Vein Thrombosis (2006) (16)
Beta-blockers in cirrhosis: therapeutic window or an aspirin for all? (2014) (16)
The use of guideline images to improve histological estimation of hepatic steatosis (2014) (16)
Emergency rescue hepatic transplantation following shunt surgery for Budd‐Chiari syndrome (1994) (16)
Ursodeoxycholic acid and primary biliary cirrhosis: EASL and AASLD guidelines. (2009) (15)
Noninvasive assessment of liver fibrosis: The clinical context and question are important (2011) (15)
Antiviral prophylaxis for the prevention of chronic hepatitis C virus in patients undergoing liver transplantation. (2013) (15)
Reversal of extrahepatic membrane cholesterol deposition in patients with chronic liver diseases by S-adenosyl-L-methionine. (1992) (15)
Angiotensin II antagonists in patients with recurrent hepatitis C virus infection after liver transplantation (2010) (15)
Liver disease in Europe (2003) (15)
Interventional treatment should be incorporated in the algorithm for the management of patients with portal vein thrombosis (2008) (15)
The management of bleeding due to portal hypertension. Part 1. The management of acute bleeding episodes. (1988) (15)
Sclerotherapy versus vasoactive drugs: are all meta-analyses the same? (2004) (15)
Single-agent immunosuppression after liver transplantation: what is possible? (2002) (15)
Peptic ulcer in patients with liver cirrhosis: a retrospective endoscopic and clinical study. (1997) (15)
An economic evaluation of vasoactive agents used in the United Kingdom for acute bleeding oesophageal varices in patients with liver cirrhosis (2007) (14)
Elevated liver enzymes in inflammatory bowel disease: the role and safety of infliximab (2016) (14)
Relief of biliary obstruction due to portal vein cavernoma using a transjugular intrahepatic portosystemic shunt (TIPS) without the need for long-term stenting. (2006) (14)
Octreotide:from basic Science to Clinical medicine (1996) (14)
EASL Meeting Report Report of the Monothematic EASL Conference on Liver Transplantation for Viral Hepatitis q (2006) (14)
Survival following the development of ascites and/or peripheral oedema in primary biliary cirrhosis: A staged prognostic model (2005) (14)
Primary prevention of variceal haemorrhage: a pharmacological approach. (2010) (14)
Experimental and clinical hepatology (1991) (14)
P1198 : Histological stage is relevant for risk-stratification in primary biliary cirrhosis (2015) (13)
Pharmacological treatment of non-alcoholic steatohepatitis: The current evidence (2007) (13)
Which transarterial therapy is best for hepatocellular carcinoma?--the evidence to date. (2010) (13)
Antiviral therapy and fibrosis progression in patients with mild-moderate hepatitis C recurrence after liver transplantation. A randomized controlled study. (2012) (13)
Patients with cirrhosis admitted to an intensive care unit. (2012) (13)
Interobserver Agreement on Endoscopic Classification of Oesophageal Varices in Children (2015) (13)
Histological subclassification of cirrhosis (2010) (13)
Incidence and outcome of colorectal cancer in liver transplant recipients: A national, multicentre analysis on 8115 patients (2018) (12)
Is bacterial DNA a better marker than endotoxin of bacterial translocation in decompensated cirrhosis? (2011) (12)
Potential indications for octreotide in gastroenterology: summary of workshop. (1993) (12)
Hepatocellular carcinoma. (2018) (12)
HCV in liver transplantation (2012) (12)
Ursodeoxycholic acid in primary sclerosing cholangitis (2012) (12)
To close the stable door before the horse has bolted. (2014) (12)
Review article: hepatocellular carcinoma: indications for liver transplantation. (2003) (12)
Liver transplant for adult hemophagocytic lymphohistiocytosis: case report and literature review. (2012) (12)
Efficacy of Loco-Regional Ablation Therapy of HCC in a Population of Liver Transplanted Patients (2008) (12)
Piperacillin-tazobactam versus ciprofloxacin plus amoxicillin in the treatment of infective episodes after liver transplantation. (2003) (12)
Transjugular intrahepatic portosystemic shunt in the management of ascites and hepatorenal syndrome. (2006) (12)
British Association for the Study of the Liver (1991) (11)
Spontaneous haemoperitoneum caused by ruptured varices in a patient with non-cirrhotic portal hypertension. (1995) (11)
Transjugular Intrahepatic Portosystemic Shunt for Portal Vein Thrombosis with and Without Underlying Cirrhosis (2007) (11)
Models for non-alcoholic fatty liver disease: a link with vascular risk. (2008) (11)
Prevalence , and Clinical Significance of Abnormal ematologic Indices in Compensated Cirrhosis (11)
British Association for the Study of the Liver (1991) (11)
Prognosis and treatment of patients with acute alcoholic hepatitis (2014) (11)
Using simulation for the economic evaluation of liver transplantation (2000) (11)
Ability of S-Adenosyl-L-Methionine to Ameliorate Lipoprotein-Induced Membrane Lipid Abnormalities and Cellular Dysfunctions in Human Liver Disease (1992) (11)
Validation of Tikhonov adaptively regularized gamma variate fitting with 24-h plasma clearance in cirrhotic patients with ascites (2011) (11)
De novo use of generic tacrolimus in liver transplantation – a single center experience with one‐yr follow‐up (2014) (11)
Systematic review of HVPG measurement: statistics versus clinical applicability. (2007) (10)
Noninvasive assessment of liver fibrosis: The need for better validation (2011) (10)
Peliosis hepatitis after liver transplantation. (1990) (10)
Bronchoscopic Needle Aspiration in Patients with Superior Vena Caval Disease (1997) (10)
Recurrence of autoimmune liver diseases after liver transplantation: clinical aspects (2012) (10)
Oxford Textbook of Clinical Hepatology (1999) (10)
Is Sustained Virological Response a Marker of Treatment Efficacy in Patients with Chronic Hepatitis C Viral Infection with No Response or Relapse to Previous Antiviral Intervention? (2013) (10)
Variceal bleeding in primary biliary cirrhosis patients: a subgroup with improved prognosis and a model to predict survival after first bleeding (2009) (9)
Bleeding from staple line erosion after esophageal transection: Effect of omeprazole (1992) (9)
Characteristics of Epstein–Barr viraemia in adult liver transplant patients: A retrospective cohort study (2014) (9)
Ursodeooxycholic acid for primary biliary cirrhosis. (2001) (9)
Cross-reactivity to lactobacillus delbrueckii/human pyruvate dehydrogenase complex-E2 characterizes primary biliary cirrhosis. (2000) (9)
Endogenous heparinoids detected by anti-Xa activity are present in blood during acute variceal bleeding in cirrhosis. A prospective study. (2014) (9)
Alcoholic hepatitis—the case for intensive management (2000) (9)
Longterm follow-up of biliary stents for retained common bile duct stones in elderly patients. (1995) (9)
Intravenous albumin in patients with cirrhosis and spontaneous bacterial peritonitis. (1999) (9)
Antituberculous therapy and acute liver failure (1995) (9)
Ursodeoxycholic Acid Improves Bilirubin but Not Albumin in Primary Biliary Cirrhosis: Further Evidence for Nonefficacy (2013) (9)
Dense fine-mapping study identifies novel disease loci and implicates coding and non-coding variation in primary Mary cirrhosis risk (2012) (9)
Bleeding varices in PBC and its prognostic significance (1990) (9)
Delta hepatitis in Lebanon. Prevalence studies and a report on six siblings with chronic delta-positive active hepatitis. (1987) (9)
Teriparatide or Alendronate in Glucocorticoid-Induced (2008) (9)
How much immunosuppression is needed after liver transplantation? (2014) (9)
Hypothalamus-pituitary dysfunction is common in patients with stable cirrhosis and abnormal low dose synacthen test. (2015) (9)
Late Intrahepatic Hematoma Complicating Transjugular Intrahepatic Portosystemic Shunt for Budd-Chiari Syndrome (2005) (8)
Predicting the advent of ascites and other complications in primary biliary cirrhosis: a staged model approach (2010) (8)
Anticoagulation after liver transplantation: a retrospective audit and case–control study (2009) (8)
Nature and standards of gastrointestinal and liver services in the United Kingdom. (1993) (8)
Validation and impact of a new technique for assessment of glomerular filtration rate in patients with liver disease (2015) (8)
Ursodeoxycholic acid and histological progression in primary biliary cirrhosis. (2003) (8)
on the quality of life of liver transplant recipients (8)
Gender disparity and MELD in liver transplantation. (2011) (8)
Severe hypermagnesaemia due to magnesium sulphate enemas in patients with hepatic coma. (1986) (8)
Development of a modified sampling and calculation method for isotope plasma clearance assessment of the glomerular filtration rate in patients with cirrhosis and ascites (2013) (8)
Transarterial therapies for hepatocellular carcinoma. (2013) (8)
Definition of Key Events: Let's Try Again (2000) (8)
Late Intrahepatic Hematoma Complicating Transjugular Intrahepatic Portosystemic Shunt for Budd-Chiari Syndrome (2007) (7)
Erratum to: “Digital image analysis of collagen assessment of progression of fibrosis in recurrent HCV after liver transplantation” [J Hepatol 2013;58:962–968] (2013) (7)
Induction immunosuppression for patients who underwent transplantation for cirrhosis caused by hepatitis C? The answer is no! (2002) (7)
The intra‐operative use of trasylol (aprotinin) in liver transplantation (1991) (7)
964 THE FARNESOID X RECEPTOR (FXR) AGONIST OBETICHOLIC ACID (OCA) INCREASES PLASMA FGF-19 CONCENTRATIONS AND DECREASES BILE ACID SYNTHESIS IN PRIMARY BILIARY CIRRHOSIS (PBC) (2012) (7)
Aprotinin and lysine analogues in high-risk cardiac surgery. (2008) (7)
An apology for beta blockers. (2014) (7)
Surveillance and diagnosis for hepatocellular carcinoma (2007) (7)
Is it difficult to obtain an optimal liver biopsy specimen? (2010) (7)
Adrenal impairment is frequent finding in stable cirrhosis and is related to disease severity (2007) (7)
Comprar Sherlock's diseases of the liver and biliary system | J. Dooley | 9781405134897 | Wiley (2011) (7)
Vapreotide in variceal bleeding. (2002) (7)
Single-Agent Immunosuppression After Liver Transplantation (2012) (7)
Case Report: Recognition of Nonhepatic Coma in the Setting of Acetaminophen Overdose (2004) (7)
Portal Hypertensive Bleeding (2010) (7)
Management of varices in cirrhosis (2011) (7)
Critically ill patients with cirrhosis and low serum sodium. (2010) (6)
Protocol biopsies in liver transplantation (2003) (6)
Is the use of albumin of value in cirrhosis? The case not so in favour, or is there an alternative? (2003) (6)
172 Heparinase I, II and III modified thromboelastography for the detection of different glycosaminoglycans' effect in cirrhotics with bacterial infection (2006) (6)
Medical management of bleeding esophageal varices. (1992) (6)
Intraperitoneal ivalon mimicking peritoneal malignancy after plugged percutaneous liver biopsy (1993) (6)
Antiviral therapy for recurrent liver graft infection with hepatitis C virus. (2009) (6)
Outcome of surgery for failed endoscopic extraction of common bile duct stones in elderly patients. (1994) (6)
Histological patterns of rejection using oral microemulsified cyclosporine and tacrolimus (FK506) as monotherapy induction after orthotopic liver transplantation. (2001) (6)
Evaluation of renal function in patients with cirrhosis. (2010) (6)
No evidence for ursodeoxycholic acid therapy in primary biliary cirrhosis A meta-analysis (1999) (6)
ALGORITHM FOR THE MANAGEMENT OF PORTAL VEIN THROMBOSIS (PVT) IN PATIENTS WITH CIRRHOSIS: A PROSPECTIVE CASE-CONTROL STUDY (2010) (6)
Nitric oxide synthase inhibitors in the hepatorenal syndrome (1993) (6)
Insights into the pathogenesis of NAFLD: The role of metabolic and pro-inflammatory mediators (2009) (6)
A clinical staging system for cirrhosis: a multicenter cohort study of 1858 patients (2011) (6)
Comparative hospital costs of liver transplantation and the treatment of complications of cirrhosis. A prospective study (1992) (6)
Monoclonal antibodies against eosinophils in liver allograft rejection. (1996) (6)
Thrombopoietin(TPO) in cirrhosis and after orthotopic liver transplantation (OLT) (1998) (6)
Improved survival with nonselective beta blockers (2008) (6)
Monitoring of Haemostasis during Liver Transplantation (2011) (6)
The management of bleeding due to portal hypertension. Part 2. Prevention of variceal rebleeding and prevention of the first bleeding episode in patients with portal hypertension. (1988) (6)
Pregnancy and liver disease. (1998) (6)
Tuberculosis Is Not a Risk Factor for Primary Biliary Cirrhosis: A Review of the Literature (2012) (5)
PELIOSIS HEPATIS AFTER LIVER TRANSPLANTATION (1990) (5)
Antiviral interventions for liver transplant patients with recurrent graft infection due to hepatitis C virus. (2013) (5)
Organ transplantation and discrimination. Patients with hepatitis B should not be given low priority. (2000) (5)
Haematological Abnormalities in Liver Disease (2008) (5)
A randomized phase II/III trial of three weekly cisplatin based transarterial chemoembolization (TACE) versus embolization (TAE) alone for hepatocellular cancer (HCC). (2010) (5)
Tacrolimus versus microemulsified cyclosporine in liver transplantation — the TMC randomised trial. Final results at one year (2002) (5)
Prognosis in primary biliary cirrhosis. A review. (1991) (5)
Advances in hepatobiliary and pancreatic diseases (1995) (5)
Benign essential tremor. (2019) (5)
Hepatorenal syndrome and ascites--questions and answers. (1999) (5)
Preface to the Twelfth Edition (2011) (5)
Antiviral therapy for recurrent hepatitis C infection after liver transplantation. (2005) (5)
Metabolism of Exogenous S-Adenosyl-L-Methionine in Patients with Liver Disease (2012) (5)
Repeated courses of transarterial embolization with polyvinyl alcohol particles: 'long life elixir' in a cirrhotic patient with unresectable hepatocellular carcinoma. (2007) (5)
Cost-effectiveness acceptability curves (2015) (5)
Heparin effect on thromboelastography after transjugular intrahepatic portosystemic shunt procedure (2009) (5)
Chapter 39 – Hemostatic Alterations in Liver Disease and Liver Transplantation (2007) (5)
Portal hypertension and hepatic sinusoidal Ulex lectin binding. (1990) (5)
α-glutathione-s-transferase in acute rejection of liver transplant recipients (1998) (5)
Kinetic Analyses of Antiviral Suppression by NS5A Inhibitors Reveal Early and Potent Inhibition of Viral Assembly and Release of Infectious Virus The rs2294918 K434E PNPLA3 Polymorphism is associated with Nonalcoholic Fatty Liver and Steatohepatitis (2013) (4)
Drug treatment for portal hypertension. (2002) (4)
Liver stiffness measurements increase after meal ingestion--an important step towards standardization. (2013) (4)
Poor prognostication for survival of individual PBC patients with Cox models (1990) (4)
Variceal and portal pressure measurement: techniques and applications. (1996) (4)
O132 EFFECTIVE STRATIFICATION OF HEPATOCELLULAR CARCINOMA RISK IN PRIMARY BILIARY CIRRHOSIS: RESULTS OF A MULTI-CENTRE INTERNATIONAL STUDY (2014) (4)
Cross-reactivity between mycobacterium gordonae and PDC-E2, the major target of anti-mitochondrial antibody, is present in Spanish but not British patients with PBC (2001) (4)
Klippel-Trénaunay syndrome, pregnancy and the liver: an unusual interplay (2012) (4)
Liver Diseases Specific to Pregnancy (2009) (4)
OC.19.2 BLEEDING-UNRELATED MORTALITY IS NOT INCREASED IN PATIENTS WITH CIRRHOSIS AND ASCITES ON TREATMENT WITH β-BLOCKERS: A META-ANALYSIS (2014) (4)
Incorporation of Donor Risk Into Liver Allocation Algorithms (2013) (4)
Higher free serum cortisol is associated with worse survival in acute variceal bleeding because of cirrhosis: a prospective study (2014) (4)
Prevention of variceal rebleeding--approach to management. (2003) (4)
Thrombopoietin concentration after orthotopic liver transplantation (2001) (4)
Error factors for transient elastography in chronic hepatitis C (2008) (4)
Original ContributionsDisseminated intravascular coagulation in liver cirrhosis: fact or fiction? (1999) (4)
Other clinical studyGrading of cellular rejection after orthotopic liver transplantation (1995) (4)
Evidence-Based Gastroenterology and Hepatology: McDonald/Evidence-Based Gastroenterology and Hepatology (2010) (4)
Advances in drug therapy for acute variceal haemorrhage. (1997) (4)
Octreotide for cirrhosis after variceal bleeding (1998) (4)
Su1804 Is Caffeine Responsible for the Hepatoprotective Effect of Coffee Consumption in Patients With Chronic Liver Diseases? A Multicentre Study (2013) (4)
Antiviral treatment after solid organ transplantation (2005) (4)
P930 BLEEDING-UNRELATED MORTALITY IS NOT INCREASED IN PATIENTS WITH CIRRHOSIS AND ASCITES ON TREATMENT WITH β-BLOCKERS: A META-ANALYSIS (2014) (4)
Transarterial therapies for hepatocellular carcinoma (HCC): a long way towards standardization. (2013) (4)
Regression of fibrosis: the need for quantitative methods of assessment. (2012) (3)
Prevention of variceal rebleeding by propranolol: Can “nonresponders” be identified? (1986) (3)
Prophylaxis for Variceal Hemorrhage (1992) (3)
Acute Management of Bleeding Oesophageal Varices (2012) (3)
Long-term immunosuppression without corticosteroids after orthotopic liver transplantation: A positive therapeutic aim (1997) (3)
Association of early CMV viraemia with hepatic arterial thrombosis (2000) (3)
USE OF THE SX-ELLA SELF-EXPANDING MESH METAL STENT IN THE MANAGEMENT OF COMPLEX VARICEAL HAEMORRHAGE: INITIAL EXPERIENCE IN A SINGLE CENTRE (2009) (3)
ASSESSMENT OF BLEEDING RISK IN CHRONIC LIVER DISEASE (1988) (3)
OC-030 Effective Stratification Of Hepatocellular Carcinoma Risk In Primary Biliary Cirrhosis: Results Of A Multi-centre International Study (2014) (3)
Endoscopic and Imaging Assessment of Esophageal Varices (1991) (3)
TIPS OUTCOMES FOR BUDD-CHIARI: A SINGLE TERTIARY CENTRE EXPERIENCE (2011) (3)
Towards a better liver allocation system. (2009) (3)
MELD and gender in the waiting list for liver transplantation. (2008) (3)
Erratum: The Royal Free Hospital Score: A Calibrated Prognostic Model for Patients With Cirrhosis Admitted to Intensive Care Unit. Comparison With Current Models and CLIF-SOFA Score (2016) (3)
488 EFFECT OF INTRA-OPERATIVE METHYLPREDNISOLONE ON POST LIVER TRANSPLANT (LT) INTENSIVE CARE UNIT (ITU) COURSE – FURTHER EVIDENCE FOR THE EXISTENCE OF HEPATO-ADRENAL SYNDROME? (2010) (3)
Liver transplantation for HCV cirrhosis: Results are not getting worse in recent years (2004) (3)
Is transarterial chemoembolization an option for all patients with unresectable hepatocellular carcinoma? (2004) (3)
30 ACUTE LIVER FAILURE: CURRENT EUROPEAN PERSPECTIVE (2010) (3)
Length versus width in liver biopsies. (2006) (3)
Noninvasive tests in the post–liver transplantation setting (2007) (3)
Hepatobiliary Disease Associated with Hypereosinophilia: A Report of Two Patients and a Review of the Literature (2011) (3)
OP01 WHO DIES FROM ALCOHOLIC LIVER DISEASE AND WHERE ARE POSSIBLE THERAPEUTIC INTERVENTIONS MISSED? AN ANALYSIS OF 755 DEATHS IN A HEALTH COMMUNITY (2011) (3)
Primary hepatic vascular leiomyosarcoma of probable portal vein origin (2)
14 Donor age does not influence progression of HCV recurrence after liver transplantation (2004) (2)
212 USE OF THE SX-ELLA SELF-EXPANDING MESH METAL STENT IN THE MANAGEMENT OF COMPLEX VARICEAL HAEMORRHAGE: INITIAL EXPERIENCE IN A SINGLE CENTRE (2009) (2)
Reply to Dr. Krag et al. (2007) (2)
268 Transarterial therapy for hepatocellular carcinoma (HCC) in cirrhosis: Is embolization as effective as chemoembolization? Systematic review of cohort and randomized studies (2006) (2)
452 Predictive factors for the absence of cellular rejection after liver transplantation in a protocol biopsy population (2003) (2)
Treatment of variceal haemorrhage (1998) (2)
Reply: Prospective validation of a noninvasive index for predicting liver fibrosis in hepatitis C virus–infected liver transplant recipients (2010) (2)
Letters From Transplant Recipients to the Family of Their Donors Are a Positive Experience for Both, and Can Help Donation (2011) (2)
Solid Organ Transplant Recipients Reconstitution of EBV-Specific T Cell Immunity (1998) (2)
Double reactivity to Ecoli/pyruvate dehydrogenase complex-E2characterises primary biliary cirrhosis (2000) (2)
Primary Prevention of Variceal Hemorrhage (2011) (2)
Copper retention in the foetus and the newborn possible relationship to Wilson's disease (1983) (2)
Liver collagen proportionate area and hepatic venous pressure gradient to sub-classify cirrhosis: Proof of concept in HCV-infected liver transplant recipients with allograft cirrhosis (2008) (2)
Evidence recommending antiviral therapy in hepatitis C. (2014) (2)
Does MMF really slow down fibrosis of HCV recurrence in liver transplant recipients? (2011) (2)
Portal hemodynamics in chronic liver disease. (1999) (2)
Liver and pancreatic transplantation (2009) (2)
Progression of HCV infection in patients with chronic kidney disease. (2009) (2)
[178] TRANSJUGULAR LIVER BIOPSY: ARE 4 CORES BETTER THAN 3 AND DOES A CASSETTE PREVENT FRAGMENTATION (2007) (2)
Recombinant factor VIIA is used in a Jehova's Witness with liver cirrhosis to correct prothrombin time, bleeding time, and thromboelastographic parameters, enabling safe percutaneous injection of hepatocellular carcinoma (1999) (2)
Attenuation of acetaminophen hepatitis by prostaglandin E2 (1994) (2)
626 In vitro immunosuppressive effect of vitamin D3 in primary biliary cirrhosis (2006) (2)
Session 6 ‒ Treatment of the Acute Bleeding Episode (2008) (2)
Levels of Alkaline Phosphatase and Bilirubin are Surrogate Endpoints of Outcomes of Patients with Primary Biliary Cirrhosis – an International Follow-up Study Short title : Alkaline phosphatase and bilirubin as surrogate endpoints in PBC (2014) (2)
Letter: ulcerative colitis in patients transplanted for primary sclerosing cholangitis (2012) (2)
The role of routine endoscopic retrograde cholangiography (ERC) in the detection of post orthotopic liver transplant biliary complications (2000) (2)
Immunogenicity and safety of a novel adjuvanted hepatitis B candidate vaccine in liver transplant patients (2004) (2)
Randomised trial of tacrolimus monotherapy versus tacrolimus/prednisolone/azathioprine in liver transplantation for HCV cirrhosis: Early rejection rates (2003) (2)
S-adenosylmethionine (SAMe) reduces cholesterol deposition in erythrocyte membranes of cirrhotic patients (1990) (2)
Liver Transplantation: Prevention and Treatment of Rejection (2010) (2)
PP-011 Collagen proportionate area: a continuous quantitative of histological collagen has the best correlation with transient elastography (2010) (2)
130 Hepatocellular carcinoma treated by orthotopic liver transplantation: Prediction for recurrence (2004) (2)
Benefits of Beta Blockade Beyond Bleeding Prophylaxis and the Role of Adherence (2012) (2)
CHARACTERISTICS ASSOCIATED WITH OUTCOME AFTER LIVER-TRANSPLANTATION AND VALIDATION OF THE DONOR-RISK-INDEX IN EUROTRANSPLANT (2010) (2)
CLINICAL-LIVER, PANCREAS, AND BILIARY TRACT (2007) (2)
Neurogenic diabetes insipidus presenting in a patient with subacute liver failure: a case report (2010) (1)
203 THE IMPACT OF THE TIPS PROCEDURE PRE-LIVER TRANSPLANT IN THE OUTCOME POST-TRANSPLANT (2008) (1)
P920 DOES PRE-TRANSPLANT ADRENAL FUNCTION HAVE AN IMPACT ON POST-TRANSPLANT RENAL FUNCTION? (2014) (1)
751 Modelling advent of complications in primary biliary cirrhosis (2003) (1)
Abnormal apoe-rich denstty lipoproteins (HDL) in plasma of cirrhotic patients are potent inhibitors of platelet aggregation (1989) (1)
Results of choledochjejunostomy in the treatment ofbiliary complications after liver transplantation in the era of nonsurgical therapies (2000) (1)
CO2 portography-investigation of choice in portal vein assessment? (1998) (1)
Spontaneous rupture of a normal portal vein causing severe retroperitoneal and intraperitoneal bleeding (1993) (1)
HISTOLOGICAL LIVER COLLAGEN PROPORTIONATE AREA PREDICTS DECOMPENSATION IN PATIENTS WITH. LIVER CIRRHOSIS OF DIFFERENT ETIOLOGIES (2010) (1)
Prevention of First Bleeding in Cirrhosis (2020) (1)
476 WHICH CORRELATION AMONG HISTOLOGICAL ASSESSMENT OF FIBROSIS, NON-INVASIVE MARKERS AND PORTAL HYPERTENSION IN HCV TRANSPLANTED PATIENTS? (2010) (1)
Fibrous ring formation in cirrhotics treated with band ligation. (2008) (1)
Isolated venous thrombosis: a new cause of acute graft failure in a non-piggyback liver transplant (case report). (2007) (1)
Sex and Gender Differences in Gastroenterology and Hepatology (2012) (1)
PTU-063 Effect of intra-operative methylprednisolone on post liver transplant intensive care unit course: further evidence for the existence of hepato-adrenal syndrome? (2010) (1)
Peg-ifn-alfa 2b With Ribavirin for the Treatment of Mild-moderate Recurrent Hepatitis C After Liver Transplantation (lt) : Impact On Fibrosis Progression. a Multicenter Randomized Controlled Study (2009) (1)
Forns index and 'FIB4' for staging of fibrosis in adults with chronic hepatitis C (2015) (1)
The Owren INR in liver disease: a way towards standardisation? (2013) (1)
O81 COST-EFFECTIVENESS OF NON-INVASIVE LIVER FIBROSIS TESTS FOR TREATMENT DECISIONS IN PATIENTS WITH CHRONIC HEPATITIS C: SYSTEMATIC REVIEW AND ECONOMIC EVALUATION (2014) (1)
Ultrasound Screening for Hepatocellular Carcinoma (1999) (1)
Propylthiouracil for alcoholic liver disease. (2011) (1)
FC12.4 Conduction and excitability properties of nerves in end-stage liver disease (2006) (1)
Incidence of adrenal dysfunction in cirrhosis (2008) (1)
[160] CLINICAL OUTCOME OF HCV-RELATED GRAFT CIRRHOSIS AND PROGNOSTIC VALUE OF HEPATIC VENOUS PRESSURE GRADIENT (2007) (1)
133 Patients with recurrent HCV infection and renal dysfunction after liver transplantation have slower fibrosis progression (2006) (1)
332 SIZE OF SAMPLE REQUIRED FOR DIGITAL IMAGE ANALYSIS MEASUREMENT OF LIVER COLLAGEN IN CIRRHOSIS (2011) (1)
Pierson syndrome (2020) (1)
Emerging Issues in the Immunopathogenesis, Diagnosis and Clinical Management of Primary Biliary Cirrhosis Associated with Systemic Sclerosis (2012) (1)
Inflammatory Bowel Disease after orthotopic liver transplantation for primary sclerosing cholangitis (2000) (1)
Coagulopathy and clotting disorders (2015) (1)
OC-053 Results Of The Uk Multi-regional Audit Of Blood Component Use In Cirrhosis (2014) (1)
Inflammatory-based panels of markers do not predict post-translpant recurrence of hepatocellular carcinoma (HCC) in patients within Milan criteria (2013) (1)
Acute liver failure: a European perspective (2010) (1)
Relationship of malnutrition to osteopenia and osteoporosis in liver cirrhosis (2001) (1)
Management of portal hypertension, Budd-Chiari syndrome and portal vein thrombosis (2011) (1)
617 FREE SERUM CORTISOL LEVELS AS A PREDICTIVE FACTOR FOR SURVIVAL IN PATIENTS WITH LIVER CIRRHOSIS AND ACUTE VARICEAL BLEEDING (2013) (1)
The Liver in Pregnancy (2011) (1)
Should Neither Sclerotherapy nor Propranolol be Used Prophylactically for Oesophageal Varices? (1992) (1)
Does HCV antiviral therapy decrease the risk of hepatocellular carcinoma? (2008) (1)
More on: enhanced thrombin generation in patients with cirrhosis‐induced coagulopathy (2011) (1)
Reply: Prophylactic variceal ligation is not recommended for patients awaiting live donor liver transplant (2008) (1)
Consultative Hemostasis and Thrombosis (2007) (1)
77 EMBOLIZATION OF LARGE SPONTANEOUS PORTOSYSTEMIC SHUNTS FOR REFRACTORY HEPATIC ENCEPHALOPATHY: A EUROPEAN MULTI-CENTER SURVEY ON SAFETY & EFFICACY (2013) (1)
β2‐Adrenergic receptors in propranolol therapy: Does down‐regulation do it? (1987) (1)
Isolation of liver associated leukocytes (LAL) from human liver graft perfusates (2001) (1)
Adrenal Insufficiency (AI) in Cirrhosis (2013) (1)
Viral hepatitis testing patterns among HIV-positive individuals in the UK Collaborative HIV Cohort (UKCHIC) study (2014) (1)
Effect of liver preservation solutions on vascular viability (1991) (1)
P17 TIPS outcomes for Budd–Chiari: a single tertiary centre experience (2011) (1)
PTU-059 Which correlation among histological assessment of fibrosis, non-invasive markers and portal hypertension in HCV transplanted patients? (2010) (1)
Nutritional status and renal function in the prognostic evaluation of cirrhosis; comparison with Pugh's score and MELD (2002) (1)
Trials in portal hypertension: Valid meta-analyses and valid randomized clinical trials: Portal Hypertension Ii (1996) (1)
Octreotide and Somatostatin in the Treatment of Bleeding Oesophageal Varices (1996) (1)
A novel scoring sytem for the histological diagnosis of hepatocellular carcinoma in cirrhotic liver (2001) (1)
Reporting patient and public involvement (2015) (1)
F.N.14 ALGORITHM FOR THE TREATMENT OF PORTAL (PVT) AND SPLANCNINC VEINS THROMBOSIS (SVT) IN PATIENTS WITH LIVER CIRRHOSIS (2010) (0)
Endoscopic Treatment of Acute Variceal Bleeding (2014) (0)
Cost-effectiveness analysis: alcoholic liver disease (2015) (0)
Outcomes After Liver Transplantation for Hcc: A Meta-Analysis (2012) (0)
The TMC study - Reply (2003) (0)
Kinetics of CMV load reductions following pre-emptive therapy with valganciclovir or intravenous ganciclovir in adult solid organ transplant patients (2004) (0)
651 RELATIONSHIP BETWEEN FEATURES OF CIRRHOTIC CARDIOMYOPATHY AND ADRENAL DYSFUNCTION IN CIRRHOSIS (2012) (0)
Meta-analysis of prophylactic RCTs for bleeding in cirrhosis (1991) (0)
379 COMPUTER-ASSISTED IMAGE ANALYSIS OF LIVER COLLAGEN IN HBV PATIENTS (2011) (0)
941 ALKALINE PHOSPHATASE VALUES ARE A SURROGATE MARKER IN PREDICTION OF TRANSPLANT FREE SURVIVAL IN PATIENTS WITH PRIMARY BILIARY CIRRHOSIS – AN INTERNATIONAL, COLLABORATIVE ANALYSIS (2013) (0)
Efficacy of high-activity lllIn-octreotide therapy: Early results (1999) (0)
Reply (2012) (0)
Systematic Error in MELD Calculation by Using Serum Creatinine Measurement in Cirrhosis (2011) (0)
Medical therapy for primary sclerosing cholangitis: authors’ reply (2011) (0)
The efficacy of tacrolimus versus microemulsified cyclosporin in prevention of early acute cellular rejection following liver transplantation: a histopathological assessment; on behalf of the UK and Republic of Ireland liver transplant study group (2002) (0)
Sixteenth sir peter freyer memorial lecture and surgical symposium September 13th & 14th, 1991 Session I (1992) (0)
Abstracts of the Joint 6th ELITA-ELTR (European Society for Organ Transplantation-European Liver and Intestine Transplant Association) 5th NHBD International Meeting. London, United Kingdom. May 13-15, 2010. (2010) (0)
Embolization of large portosystemic shunts for refractory hepatic encephalopathy: a european survey (2013) (0)
Is human herpes virus-6 & 7 in the post-transplant liver as pathogenic as cytomegalovirus? (1997) (0)
Incidence and risk factors associated with early hepatic artery thrombosis in patients undergoing orthotopic liver transplantation: A multivariable, analysis. (2007) (0)
Primary biliary cirrhosis (1992) (0)
University of Birmingham Levels of alkaline phosphatase and bilirubin are surrogate end points of outcomes of patients with primary biliary cirrhosis (2014) (0)
Duct‐to‐duct biliary reconstruction following liver transplantation for primary sclerosing cholangitis (1996) (0)
257 Liver transplantation (OLT), compared to percutaneous ethanol injection (PEI), assures better survival in patients with “early HCC”: a controlled, multicenter study (2003) (0)
178 IMMUNOSUPPRESSION AND HEPATOCELLULAR CARCINOMA RECURRENCE AFTER LIVER TRANSPLANTATION (2013) (0)
The roleof E . coli infection in the pathogenesis of primary biliary cirrhosis (2014) (0)
Liver Diseases and Pregnancy (2008) (0)
Author and Subject Index (1999) (0)
S1946 Antiviral Therapy Reduces Hepatic Venous Pressure Gradient (Hvpg) in HBV Cirrhotics with Portal Hypertension (2008) (0)
Hemodynamic monitoring: implications for randomized controlled trials and clinical practice (2004) (0)
COST-EFFECTIVENESS OF NON-INVASIVE METHODS FOR THE DIAGNOSIS OF LIVER FIBROSIS IN PATIENTS WITH CHRONIC HEPATITIS B IN THE UK (2013) (0)
Life-table analysis of survival after liver transplantation for hepatocellular carcinoma: A single centre study (2003) (0)
Late Interleukin-2 Receptor Antagonist Based lmmunosuppression Is Safe and Effective in Patients with Acute Kidney Injury after Liver Transplantation (2010) (0)
161 COLLAGEN PROPORTIONATE AREA: BEST INDEX TO PREDICT DECOMPENSATION IN PATIENTS WITH LIVER CIRRHOSIS OF DIFFERENT ETIOLOGIES (2011) (0)
Subject Index, Vol. 54, Supplement 1, 1993 (1993) (0)
Analyse transplant outcomes in distinct epochs of follow-up – Authors' reply (2006) (0)
Validation of Tikhonov adaptively regularized gamma variate fitting using 4- versus 24-hour plasma clearance (2011) (0)
226 IMPACT OF ETHNICITY ON OUTCOME FOLLOWING LIVER TRANSPLANT (LT)-AN ANALYSIS OF PRETRANSPLANT VARIABLES (2008) (0)
Corrigendum: The Royal Free Hospital Score: A Calibrated Prognostic Model for Patients With Cirrhosis Admitted to Intensive Care Unit. Comparison With Current Models and CLIF-SOFA Score (2014) (0)
197 TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNTS FOLLOWING LIVER TRANSPLANTATION CAN BE ASSOCIATED WITH A GOOD PROGNOSIS: A SINGLE CENTRE EXPERIENCE (2012) (0)
131 Female HCV cirrhosis liver transplant recipients have worse fibrosis progression due to recurrent hcv than male HCV recipients (2006) (0)
The effect of a nitric oxide synthase inhibitor on systemic haemodynamics in cirrhotic patients (1995) (0)
DONATION AFTER CARDIAC DEATH IN LIVER TRANSPLANTATION: A CALCULATED RISK (2010) (0)
Octreotide followed by sclerotherapy was not more effective than emergency injection sclerotherapy for acute variceal haemorrhage. (1998) (0)
HCV recurrence after OLT. No influence of donor age or sex mismatch on fibrosis - A prospectively biopsied cohort (2002) (0)
PTU-054 Transjugular intrahepatic portosystemic shunts following liver transplantation can be associated with a good prognosis: a single centre experience (2012) (0)
INFECTION, COAGULATION, AND VARICEAL BLEEDING IN CIRRHOSIS UT halheimer, CKT riantos, DNS amonakis, DP atch, (2005) (0)
PEG-IFN-alfa 2b WITH RIBAVIRIN FOR THE PREVENTION OF HISTOLOGICAL FIBROSIS PROGRESSION IN PATIENTS WITH HCV HEPATITIS RECURRENCE. A MULTICENTER RANDOMIZED CONTROLLED STUDY. INTERIM REPORT (2009) (0)
Toll-like receptor 4 gene in IBD : further evidence for genetic heterogeneity in Europe (2004) (0)
Elevated Hepatic Biochemistry Predicts Recurrent Primary Sclerosing Cholangitis in the First 12 Months Following Liver Transplantation (2017) (0)
Hepatocellular ballooning after liver transplantation — A possible ischaemic injury? (1990) (0)
540 Extensive homology between the major immunodominant mitochondrial antigen of primary biliary cirrhosis and helicobacter pylori does not lead to immunological crossreactivity (2004) (0)
INFECTION IN CIRRHOSIS. A SYSTEMATIC REVIEW OF MORTALITY AND PROGNOSIS: PRELIMINARY EVIDENCE FOR A NEW PROGNOSTIC STAGE (2009) (0)
Prophylactic Sclerotherapy: Yes or No! (1996) (0)
Barrett's syndrome? (1966) (0)
Raised levels of long pentraxin PTX3 are associated with the presence of a heparin effect in infected cirrhotics (2001) (0)
Acute liver failure coagulation disturbances and need for treatment (2013) (0)
OC-035 Elastography for the diagnosis of severity of fibrosis in chronic liver disease: a diagnostic test accuracy meta-analysis (2010) (0)
Can platelet count or APRI be the poor man's transient elastography in HCV patients? (2007) (0)
Summary receiver operating characteristic curves (2015) (0)
Trials in portal hypertension: consensus statements [Konsensus rapport] (1996) (0)
OP 01 EFFECTS OF RAPAMYCIN AND COBALT PROTOPORPHORINON INDUCTION OF HAEM OXYGENASE-1 AND ISCHEMIA REPERFUSION INJURY IN THE RAT LIVER (2010) (0)
In Patients With Acute Liver Failure Requiring Hemofiltration, Increased Systemic Inflammation And Endothelial Activation Is Associated With Prothrombotic Potential Evidenced By Thrombosed Hemofiltration Circuits (2012) (0)
Reliability of Serum Creatinine in Assessing Renal Function is Reduced in Patients With Cirrhosis as Compared With Patients With Organic Renal Disease (2011) (0)
Reply (2010) (0)
Early-onset dystonia with brain manganese accumulation due to SLC30A10 mutations: a new treatable disorder (2012) (0)
Early primary biliary cirrhotics demonstrate hypercoagulability by thromboelastography (2001) (0)
HCV in liver transplantation (2012) (0)
Unit costs of non-invasive liver tests and liver biopsy (2015) (0)
USE AND SAFETY PERCEPTION OF HERBAL REMEDIES IN ITALIAN PATIENTS WITH LIVER/BILIARY TRACT DISORDERS (2009) (0)
Thrombin Generation Is Normal in Most Patients with Cirrhosis despite a Prolonged INR. (2008) (0)
S1918 A Hemodynamic Response to Treatment With Non-Selective Beta-Blockers Protects Against Worsening of Thrombocytopenia in Cirrhosis (2010) (0)
Cost-effectiveness analysis: non-alcoholic fatty liver disease (2015) (0)
A case of bleeding oesophageal varices (2010) (0)
PTU-064 The use of non-heart-beating donor grafts increases perioperative resource utilisation in liver transplantation (2010) (0)
[547] A SYSTEMATIC REVIEW OF TRANSJUGULAR LIVER BIOPSY SERIES PUBLISHED BETWEEN 1978-2006: QUALITY OF SPECIMENS FOR EVALUATION OF CHRONIC HEPATITIS C AND COMPLICATIONS (2007) (0)
F-28 Systematic error in MELD calculation by using serum creatinine measurement in cirrhosis (2011) (0)
P102 The utility of radioisotope bone scans in the liver transplant assessment for hepatocellular carcinoma (2010) (0)
Comparison of hepatitis C replication dynamics during acute infection in immunocompetent hosts and re-infection of the donor liver after transplantation (2008) (0)
Reply (1995) (0)
Cost-effectiveness analysis: cirrhosis (2015) (0)
COMBINED LIVER AND KIDNEY TRANSPLANTATION IN THE TREATMENT OF VITAMIN B12 RESISTANT METHYLMALONIC ACIDAEMIA. (1999) (0)
The TMC study (2003) (0)
Predictive factors for failure to control bleeding in cirrhotic patients - Reply (2000) (0)
P0181 : Development and validation of a mathematical formula to estimate GFR in patients with cirrhosis (2015) (0)
OC1 Primary biliary cirrhosis (PBC) with baseline normal bilirubin and albumin concentrations: treatment with ursodeoxycholic acid (UDCA) improves liver-related and non liver-related survival (2010) (0)
Ectopic variceal bleeding — emergency tips alone is not enough (2002) (0)
Targeted radiopeptide therapy: High dose indium-111 octreotide for neuroendocrine tumours (1998) (0)
Letters to the Editor: Reply (2000) (0)
812 PERCUTANEOUS TREATMENT OF HEPATOCELLULAR CARCINOMA. SYSTEMATIC REVIEW AND META- ANALYSIS (2009) (0)
Seventeenth sir peter freyer memorial lecture and surgical symposium (1994) (0)
Reply to the letter by S. Montagnese et al. regarding "TIPS for refractory ascites" (2010) (0)
Methods of systematic review and economic evaluation modelling (2015) (0)
528 Endogenous heparin activity detected by antixa assay in infected cirrhotic patients (2003) (0)
P0387 : Identification of optimal cut-offs in alpha-fetoprotein and the “AFP Score” to maximise the accuracy of selection of liver transplant candidates with hepatocellular carcinoma (2015) (0)
Clinical practice and ideal liver biopsy sampling standards: Not just a matter of centimeters (2006) (0)
Phosphatidilocholine (PPC) reduces the accumulation of cholesterol in membranes of erythrocytes in cirrhotic patient (in vitro) (2000) (0)
BILIARY tract diseases. (1957) (0)
In vitro 31Phosphorus Magnetic Resonance Spectroscopy of end-stage liver disease (1991) (0)
P0178 : Sarcopenia and malnutrition predict early post-liver transplantation outcomes independently of the meld score: implications for organ allocation (2015) (0)
Bacterial infection in cirrhosis impairs coagulation by a heparin-likeeffect (2000) (0)
99 BASELINE PREDICTIVE FACTORS OF URSODEOXYCHOLIC ACID RESPONSE IN PRIMARY BILIARY CIRRHOSIS (2013) (0)
PTU-051 Does high magnification compared with conventional magnification collagen proportionate area alter its sensitivity in assessing the amount of fibrosis in chronic liver disease? (2010) (0)
SOMATOSTATIN AND ACUTE VARICEAL HEMORRHAGE. REPLY (1991) (0)
Adrenal insufficiency and liver disease -Re-search. Authors' reply (2008) (0)
OC-35 Hypothalamus-pituitary dysfunction accounts for adrenal insufficiency in cirrhosis (2011) (0)
RENAL DYSFUNCTION FOLLOWING LIVER TRANSPLANTATION (2004) (0)
P33 Serum total cortisol and plasma free cortisol response after low dose short synacthen test in stable cirrhosis (2011) (0)
A meta-analysis of emergency sclerotherapy trials (2002) (0)
The Need for Formalized Surveillance Programmes for Hepatocellular Carcinoma (2004) (0)
Role of NKG2D signalling in the activation of intrahepatic T cells. (2005) (0)
P906 AZATHIOPRINE AND EARLY TACROLIMUS LEVELS <10 ng/mL ARE PROTECTIVE AGAINST PROGRESSIVE FIBROSIS IN RECURRENT HCV POST LT (2014) (0)
200 INFECTION AND HISTORY OF INFECTION ARE INDEPENDENT OF MELD FOR PROGNOSIS IN CIRRHOSIS (2010) (0)
P854 PARENCHYMAL MEASURED FAT PROPORTIONATE AREA COULD NOT EXPLAIN THE ABNORMAL TRANSAMINASES IN NAFL PATIENTS (2014) (0)
Management of portal hypertension and Budd–Chiari syndrome (2002) (0)
Transient elastography vs. platelets or APRI score to assess fibrosis in chronic hepatitis C (2008) (0)
Literature review: cost-effectiveness analyses (hepatitis B, hepatitis C, alcoholic liver disease, non-alcoholic liver disease, cirrhosis) (2015) (0)
453 PATIENTS WITH RECURRENT HCV INFECTION AND UNDER ANGIOTENSIN RECEPTOR BLOCKERS AFTER LIVER TRANSPLANTATION HAVE SLOWER HISTOLOGICAL PROGRESSION (2009) (0)
F.N.12 BACTERIAL INFECTIONS IN CIRRHOSIS ARE ASSOCIATED WITH A POOR PROGNOSIS THAT IS NOT REFLECTED BY MELD AND UKELD SCORES (2010) (0)
Relation between liver pathology and prognosis in patients with portal hypertension (1994) (0)
633 TUMOUR SIZE OF HCC AND ITS RELATIONSHIP TO OUTCOME AFTER LIVER TRANSPLANTATION (2011) (0)
F-29 Reliability of serum creatinine in assessing renal function is reduced in patients with cirrhosis as compared with patients with organic renal disease (2011) (0)
Probability of non-invasive liver tests returning true-positive, false-negative, true-negative or false-positive results (2015) (0)
Failure to Control Bleeding and Failure to Control Rebleeding (2010) (0)
Somatic peripheral and autonomic dysfunction in chronic liver disease (2007) (0)
Bedwetting (2021) (0)
Indications, methods, andoutcomesof percutaneous liver biopsy inEngland andWales: an audit bytheBritish Society of Gastroenterology andtheRoyalCollege of Physicians ofLondon (1995) (0)
Diagnostic test accuracy of non-invasive fibrosis tests in individual studies (2015) (0)
748 Evidence that an E. coli replication primase peptide, highly homologous to the major SP100 epitope, is a possible trigger of anti-SP100 reactivity in primary biliary cirrhosis (2003) (0)
Algorithm for the management of portal vein thrombosis: a prospective study in patients with liver cirrhosis (2011) (0)
Trends in the Management of Hepatitis B Virus Infection after Liver Transplantation (2003) (0)
P0171 : Invasive fungal infections in patients with cirrhosis - subanalysis of the fungal infection risk evaluation (FIRE) study (2015) (0)
403: Characterisation of the neuropathy of chronic liver disease (2007) (0)
THE PLACE OF LIVER TRANSPLANTATION IN THE TREATMENT OF HEPATIC EPITHELOID HAEMANGIOENDOTHELIOMA: REPORT OF THE EUROPEAN LIVER TRANSPLANT REGISTRY (ELTR): 620 (2008) (0)
Bone disease in cirrhosis. Evaluation using DEXA and skeletal survey (2001) (0)
Surgery and Sclerotherapy for Treatment of Portal Hypertension and Oesophageal Varices (2012) (0)
Reply to the letter by O. Riggio et al. regarding “TIPS for refractory ascites” (2010) (0)
Long pentraxin PTX3: a potential new marker for infection in cirrhosis? (2001) (0)
Hyaluronic acid: An acute liver rejection marker? (2000) (0)
liver fibrosis An appraisal of the histopathological assessment of (2006) (0)
Is intraoperative aprotinin prophylaxis associated with the development of renal dysfunction or failure after liver transplantation? An analysis of 1067 patients. (2007) (0)
to assess clinical interventions Bernoulli cumulative SUM chart. A novel application Monitoring surgical and medical outcomes: the (2006) (0)
[179] LONG TERM FOLLOW UP OF IMMUNOSUPPRESSIVE MONOTHERAPY IN LIVER TRANSPLANTATION: TACROLIMUS AND MICROEMULSIFIED CYCLOSPORIN (2007) (0)
Literature review: diagnostic test accuracy data (2015) (0)
BG9719 (CVT-124) a highly potent adenosine A-1 receptor antagonist. Initial experience in cirrhotic patients with diuretic refractory ascites (2000) (0)
Endoscopic surveillance and primary prophylaxis for upper gastrointestinal bleeding in liver transplant candidates. (2002) (0)
Subject Index, Vol. 10, Supplement 1, 1992 (1992) (0)
Pathophysiological correlates of esophageal varices (2008) (0)
162 BACTERIAL INFECTIONS IN CIRRHOSIS ARE ASSOCIATED WITH A POOR PROGNOSIS THAT IS NOT REFLECTED BY MELD AND UKELD SCORES (2010) (0)
Parallel Sessions 16–30 (2007) (0)
OP09 TIPS outcomes for refractory ascites: a single centre experience (2011) (0)
British Association for the Study of the Liver Meeting (2000) (0)
633 HLA disparity is associated with ulcerative colitis course after transplantation for PSC (2006) (0)
652 DEVELOPMENT OF A FORMULA TO ESTIMATE GLOMERULAR FILTRATION RATE (GFR) IN PATIENTS WITH CIRRHOSIS (2012) (0)
[758] AUDIT AND PREDICTIVE FACTORS FOR ALCOHOL CONSUMPTION POST LIVER TRANSPLANTATION -MUST TRY HARDER? (2007) (0)
430 ELASTOGRAPHY FOR THE DIAGNOSIS OF SEVERITY OF FIBROSIS IN CHRONIC LIVER DISEASE. A DIAGNOSTIC TEST ACCURACY META-ANALYSIS (2010) (0)
Thepharmacokinetics ofintravenous ondansetron inpatients withhepatic impairment (1993) (0)
Management of portal hypertension, BuddeChiari syndrome and portal vein (2011) (0)
952 THE IMPACT OF PRIMARY BILIARY CIRRHOSIS (PBC) ON PERCEIVED QUALITY OF LIFE (QoL): THE UK-PBC NATIONAL STUDY (2013) (0)
HCC and liver transplantation (LT): risk factors for recurrence (2002) (0)
171 Evidence of normal thrombin generation in patients with liver cirrhosis using thromboelastography on native whole blood (2006) (0)
158 RELIABILITY OF SERUM CREATININE IN ASSESSING RENAL FUNCTION IS DIMINISHED IN PATIENTS WITH CIRRHOSIS AS COMPARED WITH PATIENTS WITH ORGANIC RENAL DISEASE (2011) (0)
High dose Indium-III octreotide therapy for disseminated carcinoid tumour (2000) (0)
Infection rates with and without T‐tube splintage of common bile duct anastomosis in liver transplantation (1998) (0)
429 ADRENAL INSUFFICIENCY IN PATIENTS WITH CIRRHOSIS AND VARICEAL BLEEDING (2010) (0)
132 Female liver transplant recipients with the same GFR as male recipients have lower meld scores — A systematic bias (2006) (0)
In vivo - in vitro correlations in hepatic 31P MR spectroscopy (1993) (0)
estimates are too imprecise : PBC patients may die from liver disease with low bilirubin values (2008) (0)
Posttransplant lymphoproliferative disorder (PTLD) in liver recipients (1998) (0)
Reply: Letter to the Editors (2010) (0)
220 MONITORING BLOOD EOSINOPHILS CAN PREDICT RESPONSE TO CORTICOSTEROIDS IN PATIENTS WITH ACUTE CELLULAR REJECTION AFTER LIVER TRANSPLANTATION (2012) (0)
Medical Management of Bleeding Varices (2007) (0)
Use of a molecularly based assay for the detection of antimitochondrial antibody M2 (2000) (0)
Degree of genomic heterogeneity correlates with a hepatocellular carcinoma (HCC) histological scoring system for HCC and putative precursor nodular lesions in cirrhotic livers (2002) (0)
51Cr-EDTA volume of distribution as a function of time and its implications for exponential and adaptive gamma variate plasma-clearance models (2013) (0)
Reply (2004) (0)
The importance of prognostic factors in cirrhosis. (2014) (0)
P19 Serum creatinine underestimates renal function in patients with cirrhosis as compared to patients with organic renal disease (2010) (0)
Hepatocellular Cancer in Cirrhotic Patients: Radiological Imaging (2009) (0)
Sinusoidal Cell Enzymes of Collagen Synthesis and Degradation in Alcoholic Liver Disease (1981) (0)
Scatterplots of cost-effectiveness analysis results (2015) (0)
A microbial mimic of the dominant T-cell autoepitope accounts for primary biliary cirrhosis-specific antibodies to a now mimicking microbial antigen (2005) (0)
[The "Liver" Study Group: portal hypertension]. (1988) (0)
Child Pugh scoring is as good as MELD and MELD-Na for short and long-term prognosis in cirrhosis: Results from a multicentre study (2013) (0)
Severe hypermagnesaemia duetomagnesium sulphate enemas in patients withhepatic coma (1998) (0)
Meta-analysis of therapeutic RCTs for redleeding in cirrhosis (1991) (0)
Endoscopic extraction ofbile duct stones: managementrelated tostonesize (1993) (0)
Patients with hepatitis C virus cirrhosis have a worse outcome when admitted to the intensive care unit compared to other causes of cirrhosis (2007) (0)
P1302 THE OPTIMAL IMMUNOSUPPRESSION REGIMEN FOR DELAYING FIBROSIS PROGRESSION IN HCV AFTER LIVER TRANSPLANTATION (2014) (0)
Transjugular liver biopsy: Not a second rate biopsy (2008) (0)
478 RECURRENCE PRIMARY BILIARY CIRRHOSIS AFTER LIVER TRANSPLANTATION: THE EFFECT OF AZATHIOPRINE (2009) (0)
Reply: Adaptation and Antituberculosis Drug–induced Liver Injury (2012) (0)
Probabilistic sensitivity analysis parameters (2015) (0)
HEPATIC ANGIOSARCOMA (HAS): THE (LAST) ABSOLUTE CONTRA-INDICATION TO LIVER TRANSPLANTATION (LT) REPORT OF THE EUROPEAN LIVER TRANSPLANT REGISTRY (ELTR).: 825 (2008) (0)
Correction of Abnormalities of Haemostasis in Chronic Liver Disease (2011) (0)
Results: meta-analysis data (2015) (0)
Long-time effects of a slow release somatostatin analogue (Lanreotide SR) on hepatic venous pressure gradient in patients with proven esophageal varices (2003) (0)
Reply to: Platelet function in patients with cirrhosis (2012) (0)
Recurrence of autoimmune liver diseases after liver transplantation: clinical aspects (2012) (0)
Factors associated with cellular rejection in liver tranplantation in a protocol biopsy population (2002) (0)
925 FACTORS ASSOCIATED WITH POOR OUTCOME IN PRIMARY BILIARY CIRRHOSIS (2013) (0)
Reopro®-modified TEG: A new technique to assess platelet function in cirrhotic patients (2000) (0)
Sandostatin LAR (long acting octreotide acetate) for carcinoid syndrome: A one year experience (2000) (0)
Variceal bleeding in non-cholestatic PBC: subgroup with improved prognosis (2001) (0)
277 Comparison of recist criteria and residual vascularity in evaluating therapeutic criteria response to embolization of hepatocellular carcinoma (2006) (0)
Case: Mistaking gastric varix with gastrointestinal stromal tumour and taking biopsy, causing catastrophic haemorrhage (2012) (0)
Cost-effectiveness analysis: hepatitis C (2015) (0)
Comprar Evidence-Based Gastroenterology And Hepatology | John W. D. McDonald | 9781405181938 | BMJ (2010) (0)
Correction: Guidelines for management of asthma in adults: I (1990) (0)
PIROXICAM INDUCED CHOLESTATIC HEPATITIS AND DIFFUSE PULMONARY FIBROSIS: CASE REPORT AND REVIEW OF LITERATURE (2009) (0)
Cellular rejection in liver transplantation is not associated with worse patient survival (2002) (0)
Chairman's introduction (2004) (0)
Short sequences of Pyruvate Dehydrogenase complex are key targets of AMA and probable templates for cross-reactivity in Primary Biliary Cirrhosis (2000) (0)
of portal hypertension: a close look at the evidence pressure gradient during pharmacological therapy Monitoring target reduction in hepatic venous (2006) (0)
Consensus Meeting on Liver Transplantation in HIV-positive Patients (2004) (0)
Hepatitis B infection among individuals attending for care in the UK Collaborative HIV Cohort (CHIC) Study (2014) (0)
The use of hepatic 31P MRS in patients with cirrhosis undergoing liver transplantation: assessment of liver function pre-transplantation and monitoring of rejection post-transplantation (1992) (0)
pegylated interferon plus ribavirin in patients with chronic hepatitis C: A prospective randomized pilot study (2012) (0)
22 Alpha-fetoprotein specific CD4+ T cell responses are unmasked during transarterial embolisation in hepatocellular carcinoma (2006) (0)
631 Influence of the predisposing DRB1*08 allele and of the protective HLA-DRB1*11 allele over the expression of primary biliary cirrhosis-specific anti-mitochondrial and anti-nuclear reactivities (2006) (0)
Azathioprine Immunosuppression Is Protective Against Recurrence of Primary Biliary Cirrhosis after Liver Transplantation. (2014) (0)
632 DOES THE NUMBER OF HCC NODULES IN CIRRHOSIS IMPACT ON OUTCOME AFTER LIVER TRANSPLANTATION (2011) (0)
Chapter 6 – Organ Allocation: The European Models (2015) (0)
Response to the letter about 'Development of a modified sampling and calculation method for isotope plasma clearance assessment of glomerular filtration rate in patients with cirrhosis and ascites'. (2014) (0)
569 THE UTILITY OF RADIOISOTOPE BONE SCANS IN LIVER TRANSPLANT ASSESSMENT FOR HCC (2011) (0)
The UK-PBC risk score: Derivation and validation of a risk score to predict liver events in the UK-PBC research cohort (2015) (0)
Prognosis and treatment of patients with acute alcoholic (2014) (0)
109 CORRELATION OF LIVER “COLLAGEN PROPORTIONATE AREA” BY COMPUTER ASSISTED IMAGE ANALYSIS AND HEPATIC VENOUS PRESSURE GRADIENT IN PATIENTS WITH RECURRENT HCV INFECTION AFTER LIVER TRANSPLANTATION (2008) (0)
Session 1 ‒ Definition of Key Events: Lets's Try Again (2008) (0)
Association of peripheral and graft eosinophilia in acute rejection episodes of liver transplant patients (1996) (0)
TIPS IN TREATMENT OF GASTRIC VARICES. AUTHORS' REPLY (1998) (0)
THE USE OF NON HEART BEATING DONOR GRAFTS INCREASES PERIOPERATIVE RESOURCE UTILISATION IN LIVER TRANSPLANTATION (2010) (0)
Ursodeoxycholic acid, chelating agents, and zinc in the treatment of metabolic liver diseases (2014) (0)
Hedgehog Pathway Targeted by Vitamin E Therapy in NASH Defining Optimal Laboratory Response Criteria in UDCA Treated Primary Biliary Cirrhosis. Results of an International Multicenter Long-term Follow-up Study (2013) (0)
Mycophenolate mofetil (MMF) monotherapy improves renal dysfunction in orthotopic liver transplant (OLT) recipients without increased risk of rejection (2002) (0)
Nonalcoholic Fatty Liver Disease ’ ’ in a Developing Country : A Different Perspective To the (0)
Antiviral treatment after solid organ transplantation [5] (multiple letters) (2005) (0)

This paper list is powered by the following services:

Other Resources About Andrew Kenneth Burroughs

en.wikipedia.org

What Schools Are Affiliated With Andrew Kenneth Burroughs?

Andrew Kenneth Burroughs is affiliated with the following schools:

Andrew Kenneth Burroughs's Academic­Influence.com Rankings